Artivion Inc. (AORT) NEW YORK STOCK EXCHANGE INC.
$19.94 (0.37) (-1.82%)
Market Cap: $836.77M
As of 04/17/24 04:00 PM EDT. Market closed.
Artivion Inc. (AORT)
NEW YORK STOCK EXCHANGE INC.
$19.94
(0.37) (-1.82%)
Market Cap: $836.77M
As of 04/17/24 04:00 PM EDT. Market closed.
cryolife, headquartered in georgia, is a leader in the processing and distribution of human tissues for use in cardiac and vascular surgeries. cryolife using its proprietary synergraft® technology processes the cryovalve® sg pulmonary heart valve and cryopatch® sg pulmonary cardiac patch. cryolife’s bioglue® surgical adhesive is approved in the u.s. for use as an adjunct to sutures and ... read more
cryolife, headquartered in georgia, is a leader in the processing and distribution of human tissues for use in cardiac and vascular surgeries. cryolife using its proprietary synergraft® technology processes the cryovalve® sg pulmonary heart valve and cryopatch® sg pulmonary cardiac patch. cryolife’s bioglue® surgical adhesive is approved in the u.s. for use as an adjunct to sutures and staples to help control bleeding, ce marked in the european community, approved in canada and australia for use in soft tissue repair, and in japan for use in the repair of aortic dissections. cryolife’s cardiogenesis specializes in the treatment of severe angina using a laser console system and fiber-optic handpieces to perform a surgical procedure known as transmyocardial revascularization (tmr). cryolife markets the hero® graft, which provides vascular access for hemodialysis patients. cryolife distributes perclot®, an absorbable powdered hemostat, in international markets. cryolife’s biofoam® surgica read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Stanton Marshall S. | SVP, Clinical & MD Affair | Mar 20, 2024 | Sale | $20.39 | 2,183 | 44,511 | 83,296 | Mar 21, 2024, 05:14 PM |
GREEN ANDREW M | VP Regulatory | Mar 15, 2024 | Sale | $20.00 | 1,462 | 29,240 | 41,121 | Mar 18, 2024, 06:09 PM |
GREEN ANDREW M | VP Regulatory | Mar 14, 2024 | Sale | $20.00 | 3,994 | 79,880 | 42,583 | Mar 15, 2024, 05:20 PM |
Getz Matthew A | VP, Human Resources | Mar 12, 2024 | Sale | $19.94 | 5,000 | 99,719 | 43,536 | Mar 14, 2024, 09:06 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 26, 2024 | Sale | $20.27 | 2,134 | 43,259 | 137,888 | Mar 14, 2024, 08:38 PM |
Stanton Marshall S. | SVP, Clinical & MD Affair | Feb 26, 2024 | Sale | $20.27 | 3,007 | 60,955 | 81,726 | Mar 14, 2024, 08:36 PM |
Maney Rochelle L. | VP, Quality | Feb 26, 2024 | Sale | $20.27 | 2,282 | 46,259 | 44,518 | Mar 14, 2024, 08:33 PM |
Holloway Jean F | SVP, General Counsel | Feb 26, 2024 | Sale | $20.27 | 2,838 | 57,529 | 166,852 | Mar 14, 2024, 08:31 PM |
GREEN ANDREW M | VP Regulatory | Feb 26, 2024 | Sale | $20.27 | 2,367 | 47,982 | 44,580 | Mar 14, 2024, 08:29 PM |
Davis John E | Chief Commercial Officer | Feb 26, 2024 | Sale | $20.27 | 3,461 | 70,158 | 162,572 | Mar 14, 2024, 08:27 PM |
Stanton Marshall S. | SVP, Clinical & MD Affair | Feb 27, 2024 | Sale | $19.83 | 465 | 9,223 | 81,261 | Mar 14, 2024, 08:25 PM |
Maney Rochelle L. | VP, Quality | Feb 27, 2024 | Sale | $19.83 | 370 | 7,339 | 44,148 | Mar 14, 2024, 08:23 PM |
GREEN ANDREW M | VP Regulatory | Feb 27, 2024 | Sale | $19.83 | 421 | 8,350 | 44,159 | Mar 14, 2024, 08:20 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 27, 2024 | Sale | $19.83 | 325 | 6,446 | 137,563 | Mar 14, 2024, 08:18 PM |
Davis John E | Chief Commercial Officer | Feb 27, 2024 | Sale | $19.83 | 584 | 11,583 | 161,988 | Mar 14, 2024, 08:16 PM |
Mackin James P | President & CEO | Feb 26, 2024 | Sale | $20.27 | 30,836 | 625,080 | 696,253 | Mar 14, 2024, 08:14 PM |
Holloway Jean F | SVP, General Counsel | Feb 27, 2024 | Sale | $19.83 | 485 | 9,620 | 166,367 | Mar 14, 2024, 08:11 PM |
Horton Amy | VP, Chief Accounting Officer | Mar 05, 2024 | Sale | $18.72 | 1,152 | 21,568 | 139,989 | Mar 14, 2024, 08:09 PM |
Stanton Marshall S. | SVP, Clinical & MD Affair | Mar 01, 2024 | Sale | $18.72 | 1,506 | 28,195 | 85,479 | Mar 14, 2024, 08:06 PM |
Getz Matthew A | VP, Human Resources | Feb 26, 2024 | Sale | $20.27 | 2,280 | 46,218 | 46,440 | Mar 14, 2024, 08:04 PM |
Getz Matthew A | VP, Human Resources | Feb 27, 2024 | Sale | $19.83 | 325 | 6,446 | 46,115 | Mar 14, 2024, 08:02 PM |
Maney Rochelle L. | VP, Quality | Mar 05, 2024 | Sale | $18.72 | 1,157 | 21,662 | 46,569 | Mar 14, 2024, 08:00 PM |
Mackin James P | President & CEO | Feb 27, 2024 | Sale | $19.83 | 4,837 | 95,939 | 691,416 | Mar 14, 2024, 07:57 PM |
Holloway Jean F | SVP, General Counsel | Mar 05, 2024 | Sale | $18.72 | 2,380 | 44,559 | 169,711 | Mar 14, 2024, 07:55 PM |
GREEN ANDREW M | VP Regulatory | Mar 05, 2024 | Sale | $18.72 | 1,160 | 21,718 | 46,577 | Mar 14, 2024, 07:53 PM |
Getz Matthew A | VP, Human Resources | Mar 05, 2024 | Sale | $18.72 | 1,157 | 21,661 | 48,536 | Mar 14, 2024, 07:51 PM |
Davis John E | Chief Commercial Officer | Mar 05, 2024 | Sale | $18.72 | 2,022 | 37,856 | 165,690 | Mar 14, 2024, 07:48 PM |
Mackin James P | President & CEO | Mar 05, 2024 | Sale | $18.72 | 13,996 | 262,037 | 706,038 | Mar 14, 2024, 07:45 PM |
Mackin James P | President & CEO | Mar 05, 2024 | Sale | $18.72 | 13,996 | 262,037 | 705,562 | Mar 07, 2024, 06:20 PM |
Holloway Jean F | SVP, General Counsel | Mar 05, 2024 | Sale | $18.72 | 2,380 | 44,559 | 169,669 | Mar 07, 2024, 06:16 PM |
Davis John E | Chief Commercial Officer | Mar 05, 2024 | Sale | $18.72 | 2,022 | 37,856 | 165,637 | Mar 07, 2024, 06:14 PM |
Getz Matthew A | VP, Human Resources | Mar 05, 2024 | Sale | $18.72 | 1,157 | 21,661 | 48,503 | Mar 07, 2024, 06:12 PM |
Maney Rochelle L. | VP, Quality | Mar 05, 2024 | Sale | $18.72 | 1,157 | 21,662 | 46,536 | Mar 07, 2024, 06:10 PM |
GREEN ANDREW M | VP Regulatory | Mar 05, 2024 | Sale | $18.72 | 1,160 | 21,718 | 46,541 | Mar 07, 2024, 06:07 PM |
Stanton Marshall S. | SVP, Clinical & MD Affair | Mar 05, 2024 | Sale | $18.72 | 1,506 | 28,195 | 85,438 | Mar 07, 2024, 06:05 PM |
Horton Amy | VP, Chief Accounting Officer | Mar 05, 2024 | Sale | $18.72 | 1,152 | 21,568 | 139,957 | Mar 07, 2024, 06:01 PM |
Tyrs Florian | VP, Global Operations | Feb 27, 2024 | Sale | $19.83 | 339 | 6,724 | 21,558 | Feb 29, 2024, 05:43 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 27, 2024 | Sale | $19.83 | 325 | 6,446 | 137,531 | Feb 29, 2024, 05:39 PM |
Mackin James P | President & CEO | Feb 27, 2024 | Sale | $19.83 | 4,837 | 95,939 | 690,940 | Feb 29, 2024, 05:36 PM |
Holloway Jean F | SVP, General Counsel | Feb 27, 2024 | Sale | $19.83 | 485 | 9,620 | 166,325 | Feb 29, 2024, 05:34 PM |
Davis John E | Chief Commercial Officer | Feb 27, 2024 | Sale | $19.83 | 584 | 11,583 | 161,935 | Feb 29, 2024, 05:32 PM |
Maney Rochelle L. | VP, Quality | Feb 27, 2024 | Sale | $19.83 | 370 | 7,339 | 44,115 | Feb 29, 2024, 05:30 PM |
Getz Matthew A | VP, Human Resources | Feb 27, 2024 | Sale | $19.83 | 325 | 6,446 | 46,082 | Feb 29, 2024, 05:27 PM |
GREEN ANDREW M | VP Regulatory | Feb 27, 2024 | Sale | $19.83 | 421 | 8,350 | 44,123 | Feb 29, 2024, 05:21 PM |
Stanton Marshall S. | SVP, Clinical & MD Affair | Feb 27, 2024 | Sale | $19.83 | 465 | 9,223 | 81,220 | Feb 29, 2024, 05:18 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 26, 2024 | Sale | $20.27 | 2,166 | 43,907 | 137,856 | Feb 28, 2024, 05:25 PM |
Mackin James P | President & CEO | Feb 26, 2024 | Sale | $20.27 | 31,312 | 634,729 | 695,777 | Feb 28, 2024, 05:22 PM |
Holloway Jean F | SVP, General Counsel | Feb 26, 2024 | Sale | $20.27 | 2,880 | 58,381 | 166,810 | Feb 28, 2024, 05:18 PM |
Maney Rochelle L. | VP, Quality | Feb 26, 2024 | Sale | $20.27 | 2,315 | 46,928 | 44,485 | Feb 28, 2024, 05:16 PM |
Davis John E | Chief Commercial Officer | Feb 26, 2024 | Sale | $20.27 | 3,514 | 71,233 | 162,519 | Feb 28, 2024, 05:12 PM |
Getz Matthew A | VP, Human Resources | Feb 26, 2024 | Sale | $20.27 | 2,313 | 46,887 | 46,407 | Feb 28, 2024, 05:07 PM |
GREEN ANDREW M | VP Regulatory | Feb 26, 2024 | Sale | $20.27 | 2,403 | 48,711 | 44,544 | Feb 28, 2024, 05:04 PM |
Stanton Marshall S. | SVP, Clinical & MD Affair | Feb 26, 2024 | Sale | $20.27 | 3,048 | 61,786 | 81,685 | Feb 28, 2024, 05:01 PM |
Tyrs Florian | VP, Global Operations | Feb 26, 2024 | Sale | $20.27 | 893 | 18,103 | 21,897 | Feb 28, 2024, 04:58 PM |
Holloway Jean F | SVP, General Counsel | Feb 20, 2024 | Sale | $18.86 | 3,527 | 66,537 | 133,514 | Feb 22, 2024, 05:37 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 20, 2024 | Sale | $18.86 | 1,695 | 31,976 | 122,711 | Feb 22, 2024, 05:35 PM |
Davis John E | Chief Commercial Officer | Feb 20, 2024 | Sale | $18.86 | 2,556 | 48,219 | 128,673 | Feb 22, 2024, 05:32 PM |
Maney Rochelle L. | VP, Quality | Feb 20, 2024 | Sale | $18.86 | 407 | 7,678 | 29,123 | Feb 22, 2024, 05:29 PM |
Getz Matthew A | VP, Human Resources | Feb 20, 2024 | Sale | $18.86 | 1,695 | 31,976 | 29,058 | Feb 22, 2024, 05:26 PM |
Tyrs Florian | VP, Global Operations | Feb 20, 2024 | Sale | $18.86 | 249 | 4,697 | 16,253 | Feb 22, 2024, 05:22 PM |
Mackin James P | President & CEO | Feb 20, 2024 | Option Exercise | $16.30 | 59,225 | 965,367 | 611,105 | Feb 22, 2024, 05:08 PM |
Mackin James P | President & CEO | Feb 20, 2024 | Sale | $18.85 | 72,069 | 1,358,818 | 551,880 | Feb 22, 2024, 05:08 PM |
Holloway Jean F | SVP, General Counsel | Jan 02, 2024 | Option Exercise | $16.30 | 21,229 | 346,033 | 154,749 | Jan 04, 2024, 04:25 PM |
Holloway Jean F | SVP, General Counsel | Jan 02, 2024 | Sale | $18.00 | 21,229 | 382,122 | 133,520 | Jan 04, 2024, 04:25 PM |
Davis John E | Senior VP, Global Sales | Jan 02, 2024 | Option Exercise | $16.30 | 13,562 | 221,061 | 142,295 | Jan 04, 2024, 04:22 PM |
Davis John E | Senior VP, Global Sales | Jan 02, 2024 | Sale | $18.00 | 13,562 | 244,116 | 128,733 | Jan 04, 2024, 04:22 PM |
Horton Amy | VP, Chief Accounting Officer | Dec 15, 2023 | Option Exercise | $16.30 | 14,397 | 234,671 | 138,437 | Dec 19, 2023, 05:23 PM |
Horton Amy | VP, Chief Accounting Officer | Dec 15, 2023 | Sale | $19.00 | 14,397 | 273,543 | 124,040 | Dec 19, 2023, 05:23 PM |
Berry Lance A | Executive VP, CFO | Dec 06, 2023 | Option Exercise | $17.83 | 42,064 | 750,001 | 42,064 | Dec 08, 2023, 09:16 AM |
Horton Amy | VP, Chief Accounting Officer | Dec 06, 2023 | Option Exercise | $17.83 | 20,191 | 360,006 | 124,040 | Dec 08, 2023, 09:09 AM |
Horton Amy | VP, Chief Accounting Officer | Nov 27, 2023 | Option Exercise | $17.51 | 1,750 | 30,643 | 103,849 | Nov 29, 2023, 09:15 AM |
Horton Amy | VP, Chief Accounting Officer | Nov 27, 2023 | Sale | $17.34 | 2,101 | 36,431 | 105,599 | Nov 29, 2023, 09:15 AM |
Tyrs Florian | VP, Global Operations | Aug 08, 2023 | Option Exercise | $16.79 | 2,107 | 35,377 | 16,502 | Aug 10, 2023, 08:48 AM |
THOMSON ROBERT C | VP Research & Development | Jun 09, 2023 | Option Exercise | $15.49 | 5,126 | 79,402 | 5,126 | Jun 12, 2023, 09:46 PM |
Maier Dennis B | SVP, Operations | Jun 06, 2023 | Sale | $15.27 | 16,254 | 248,163 | 35,102 | Jun 08, 2023, 05:24 PM |
Getz Matthew A | VP, Human Resources | Jun 07, 2023 | Sale | $15.88 | 6,329 | 100,483 | 30,387 | Jun 08, 2023, 05:20 PM |
Maier Dennis B | SVP, Operations | Mar 02, 2023 | Sale | $13.41 | 1,121 | 15,035 | 50,978 | Mar 03, 2023, 06:20 PM |
Maney Rochelle L. | VP, Quality | Mar 02, 2023 | Sale | $13.41 | 821 | 11,011 | 29,530 | Mar 03, 2023, 06:18 PM |
Horton Amy | VP, Chief Accounting Officer | Mar 02, 2023 | Sale | $13.41 | 702 | 9,415 | 107,700 | Mar 03, 2023, 06:13 PM |
Getz Matthew A | VP, Human Resources | Mar 02, 2023 | Sale | $13.41 | 702 | 9,415 | 36,716 | Mar 03, 2023, 06:11 PM |
Mackin James P | President & CEO | Mar 02, 2023 | Sale | $13.41 | 9,990 | 133,984 | 551,880 | Mar 03, 2023, 06:07 PM |
GREEN ANDREW M | VP Regulatory | Mar 02, 2023 | Sale | $13.41 | 825 | 11,065 | 25,567 | Mar 03, 2023, 06:05 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 02, 2023 | Sale | $13.41 | 1,401 | 18,790 | 347,217 | Mar 03, 2023, 06:01 PM |
Stanton Marshall S. | SVP, Clinical & MD Affair | Mar 02, 2023 | Sale | $13.41 | 907 | 12,165 | 52,077 | Mar 03, 2023, 05:56 PM |
Davis John E | Senior VP, Global Sales | Mar 02, 2023 | Sale | $13.41 | 1,121 | 15,035 | 128,733 | Mar 03, 2023, 05:52 PM |
Holloway Jean F | SVP, General Counsel | Mar 02, 2023 | Sale | $13.41 | 907 | 12,165 | 133,520 | Mar 03, 2023, 05:48 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 27, 2023 | Sale | $12.94 | 1,419 | 18,359 | 106,112 | Mar 01, 2023, 06:52 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 27, 2023 | Sale | $12.94 | 3,094 | 40,030 | 344,039 | Mar 01, 2023, 06:49 PM |
Holloway Jean F | SVP, General Counsel | Feb 27, 2023 | Sale | $12.94 | 1,960 | 25,358 | 130,764 | Mar 01, 2023, 06:46 PM |
Davis John E | Senior VP, Global Sales | Feb 27, 2023 | Sale | $12.94 | 2,393 | 30,961 | 126,191 | Mar 01, 2023, 06:44 PM |
Maney Rochelle L. | VP, Quality | Feb 27, 2023 | Option Exercise | $12.94 | 790 | 10,221 | 28,467 | Mar 01, 2023, 06:41 PM |
Maney Rochelle L. | VP, Quality | Feb 28, 2023 | Sale | $13.24 | 406 | 5,374 | 28,061 | Mar 01, 2023, 06:41 PM |
Maney Rochelle L. | VP, Quality | Feb 27, 2023 | Sale | $12.94 | 878 | 11,360 | 25,017 | Mar 01, 2023, 06:41 PM |
GREEN ANDREW M | VP Regulatory | Feb 27, 2023 | Sale | $12.94 | 1,747 | 22,603 | 24,102 | Mar 01, 2023, 06:39 PM |
Mackin James P | President & CEO | Feb 27, 2023 | Sale | $12.94 | 22,630 | 292,787 | 540,052 | Mar 01, 2023, 06:36 PM |
Maier Dennis B | SVP, Operations | Feb 27, 2023 | Sale | $12.94 | 2,330 | 30,146 | 48,436 | Mar 01, 2023, 06:32 PM |
Stanton Marshall S. | SVP, Clinical & MD Affair | Feb 27, 2023 | Sale | $12.94 | 2,337 | 30,236 | 49,321 | Mar 01, 2023, 06:27 PM |
Getz Matthew A | VP, Human Resources | Feb 27, 2023 | Sale | $12.94 | 1,600 | 20,701 | 35,128 | Mar 01, 2023, 06:22 PM |
Getz Matthew A | VP, Human Resources | Feb 19, 2023 | Option Exercise | $13.96 | 1,407 | 19,642 | 30,414 | Feb 21, 2023, 08:52 AM |
Getz Matthew A | VP, Human Resources | Feb 17, 2023 | Option Exercise | $13.96 | 363 | 5,067 | 31,539 | Feb 21, 2023, 08:52 AM |
Holloway Jean F | SVP, General Counsel | Feb 17, 2023 | Option Exercise | $13.96 | 1,985 | 27,711 | 124,327 | Feb 21, 2023, 08:49 AM |
Holloway Jean F | SVP, General Counsel | Feb 19, 2023 | Option Exercise | $13.96 | 1,700 | 23,732 | 121,539 | Feb 21, 2023, 08:49 AM |
Maney Rochelle L. | VP, Quality | Feb 17, 2023 | Option Exercise | $13.96 | 403 | 5,626 | 23,539 | Feb 21, 2023, 08:46 AM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2023 | Option Exercise | $13.96 | 2,630 | 36,715 | 332,824 | Feb 21, 2023, 08:40 AM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 17, 2023 | Option Exercise | $13.96 | 635 | 8,865 | 334,928 | Feb 21, 2023, 08:40 AM |
Maier Dennis B | SVP, Operations | Feb 17, 2023 | Option Exercise | $13.96 | 380 | 5,305 | 42,085 | Feb 21, 2023, 08:36 AM |
Maier Dennis B | SVP, Operations | Feb 19, 2023 | Option Exercise | $13.96 | 1,407 | 19,642 | 40,960 | Feb 21, 2023, 08:36 AM |
Horton Amy | VP, Chief Accounting Officer | Feb 19, 2023 | Option Exercise | $13.96 | 1,365 | 19,055 | 101,193 | Feb 21, 2023, 08:33 AM |
Horton Amy | VP, Chief Accounting Officer | Feb 17, 2023 | Option Exercise | $13.96 | 363 | 5,067 | 102,300 | Feb 21, 2023, 08:33 AM |
Horton Amy | VP, Chief Accounting Officer | Feb 17, 2023 | Option Exercise | $10.24 | 20,713 | 212,101 | 117,663 | Feb 21, 2023, 08:33 AM |
Horton Amy | VP, Chief Accounting Officer | Feb 17, 2023 | Sale | $14.09 | 18,000 | 253,553 | 102,663 | Feb 21, 2023, 08:33 AM |
Mackin James P | President & CEO | Feb 19, 2023 | Option Exercise | $13.96 | 10,692 | 149,260 | 494,391 | Feb 21, 2023, 08:29 AM |
Mackin James P | President & CEO | Feb 17, 2023 | Option Exercise | $13.96 | 2,740 | 38,250 | 502,944 | Feb 21, 2023, 08:29 AM |
Davis John E | Senior VP, Global Sales | Feb 19, 2023 | Option Exercise | $13.96 | 2,247 | 31,368 | 117,574 | Feb 21, 2023, 08:26 AM |
Davis John E | Senior VP, Global Sales | Feb 17, 2023 | Option Exercise | $13.96 | 586 | 8,181 | 119,431 | Feb 21, 2023, 08:26 AM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 14, 2023 | Option Exercise | $10.24 | 36,822 | 377,057 | 367,463 | Feb 16, 2023, 05:41 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 14, 2023 | Sale | $13.22 | 31,900 | 421,874 | 335,563 | Feb 16, 2023, 05:41 PM |
Mackin James P | President & CEO | Feb 14, 2023 | Option Exercise | $10.24 | 65,549 | 671,222 | 562,184 | Feb 16, 2023, 05:36 PM |
Mackin James P | President & CEO | Feb 14, 2023 | Sale | $13.22 | 56,500 | 747,207 | 505,684 | Feb 16, 2023, 05:36 PM |
Davis John E | Senior VP, Global Sales | Feb 13, 2023 | Option Exercise | $10.24 | 8,745 | 89,549 | 120,017 | Feb 15, 2023, 08:48 AM |
Horton Amy | VP, Chief Accounting Officer | Dec 14, 2022 | Option Exercise | $13.21 | 2,000 | 26,420 | 99,950 | Dec 16, 2022, 08:35 AM |
Horton Amy | VP, Chief Accounting Officer | Dec 14, 2022 | Sale | $13.57 | 3,226 | 43,783 | 101,950 | Dec 16, 2022, 08:35 AM |
Maney Rochelle L. | VP, Quality | Nov 04, 2022 | Option Exercise | $11.18 | 214 | 2,393 | 12,111 | Nov 07, 2022, 04:53 PM |
Maney Rochelle L. | VP, Quality | Aug 16, 2022 | Sale | $22.96 | 7,161 | 164,409 | 12,325 | Aug 18, 2022, 04:24 PM |
Maier Dennis B | SVP, Operations | Aug 09, 2022 | Sale | $21.61 | 5,762 | 124,513 | 28,424 | Aug 10, 2022, 05:12 PM |
SEMEDO ANTHONY B. | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 27,870 | Jun 03, 2022, 04:48 PM |
Salveson Jon W | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 107,517 | Jun 03, 2022, 04:46 PM |
Burbank Jeffrey H | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 31,473 | Jun 03, 2022, 04:45 PM |
Bullock James | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 46,324 | Jun 03, 2022, 04:39 PM |
Borgstrom Marna P | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 26,765 | Jun 03, 2022, 04:36 PM |
BEVEVINO DANIEL J | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 127,738 | Jun 03, 2022, 04:34 PM |
ACKERMAN THOMAS F | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 127,573 | Jun 03, 2022, 04:31 PM |
Maney Rochelle L. | VP, Quality | Mar 08, 2022 | Option Exercise | $20.32 | 81 | 1,646 | 19,486 | Mar 09, 2022, 04:45 PM |
Barthold Franz Peter | VP, Research & Development | Mar 08, 2022 | Option Exercise | $20.32 | 76 | 1,544 | 20,005 | Mar 09, 2022, 04:44 PM |
Maier Dennis B | Vice President, Operations | Mar 05, 2022 | Option Exercise | $21.69 | 1,090 | 23,642 | 28,739 | Mar 07, 2022, 04:34 PM |
Mackin James P | President & CEO | Mar 05, 2022 | Option Exercise | $21.69 | 13,029 | 282,599 | 381,909 | Mar 07, 2022, 04:33 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 05, 2022 | Option Exercise | $21.69 | 2,146 | 46,547 | 294,290 | Mar 07, 2022, 04:31 PM |
Horton Amy | VP, Chief Accounting Officer | Mar 05, 2022 | Option Exercise | $21.69 | 1,132 | 24,553 | 93,537 | Mar 07, 2022, 04:27 PM |
Holloway Jean F | SVP, General Counsel | Mar 05, 2022 | Option Exercise | $21.69 | 1,799 | 39,020 | 101,502 | Mar 07, 2022, 04:22 PM |
Davis John E | Senior VP, Global Sales | Mar 05, 2022 | Option Exercise | $21.69 | 1,799 | 39,020 | 88,049 | Mar 07, 2022, 04:20 PM |
Barthold Franz Peter | VP, Research & Development | Mar 05, 2022 | Option Exercise | $21.69 | 602 | 13,057 | 20,184 | Mar 07, 2022, 04:17 PM |
Maney Rochelle L. | VP, Quality | Feb 27, 2022 | Option Exercise | $19.35 | 398 | 7,701 | 19,567 | Mar 01, 2022, 05:02 PM |
Maier Dennis B | Vice President, Operations | Feb 19, 2022 | Option Exercise | $17.75 | 282 | 5,006 | 22,519 | Feb 22, 2022, 05:02 PM |
Mackin James P | President & CEO | Feb 19, 2022 | Option Exercise | $17.75 | 3,204 | 56,871 | 345,083 | Feb 22, 2022, 05:00 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2022 | Option Exercise | $17.75 | 526 | 9,337 | 284,632 | Feb 22, 2022, 04:59 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 19, 2022 | Option Exercise | $17.75 | 256 | 4,544 | 89,687 | Feb 22, 2022, 04:57 PM |
Holloway Jean F | SVP, General Counsel | Feb 19, 2022 | Option Exercise | $17.75 | 421 | 7,473 | 94,226 | Feb 22, 2022, 04:56 PM |
Getz Matthew A | VP, Human Resources | Feb 19, 2022 | Option Exercise | $17.75 | 244 | 4,331 | 13,921 | Feb 22, 2022, 04:55 PM |
Davis John E | Senior VP, Global Sales | Feb 19, 2022 | Option Exercise | $17.75 | 402 | 7,136 | 80,917 | Feb 22, 2022, 04:53 PM |
Barthold Franz Peter | VP, Research & Development | Feb 19, 2022 | Option Exercise | $17.75 | 353 | 6,266 | 15,893 | Feb 22, 2022, 04:52 PM |
Stanton Marshall S. | SVP, Clinical & MD Affair | Feb 17, 2022 | Option Exercise | $17.50 | 772 | 13,510 | 11,342 | Feb 22, 2022, 07:33 AM |
Maney Rochelle L. | VP, Quality | Feb 17, 2022 | Option Exercise | $17.50 | 979 | 17,133 | 15,175 | Feb 22, 2022, 07:32 AM |
Maier Dennis B | Vice President, Operations | Feb 17, 2022 | Option Exercise | $17.50 | 1,463 | 25,603 | 22,801 | Feb 22, 2022, 07:31 AM |
Mackin James P | President & CEO | Feb 17, 2022 | Option Exercise | $17.50 | 16,133 | 282,328 | 348,287 | Feb 22, 2022, 07:30 AM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 17, 2022 | Option Exercise | $17.50 | 2,514 | 43,995 | 285,158 | Feb 22, 2022, 07:29 AM |
Horton Amy | VP, Chief Accounting Officer | Feb 17, 2022 | Option Exercise | $17.50 | 1,418 | 24,815 | 89,943 | Feb 22, 2022, 07:28 AM |
Holloway Jean F | SVP, General Counsel | Feb 17, 2022 | Option Exercise | $17.50 | 3,579 | 62,633 | 96,078 | Feb 22, 2022, 07:27 AM |
Getz Matthew A | VP, Human Resources | Feb 17, 2022 | Option Exercise | $17.50 | 1,428 | 24,990 | 14,165 | Feb 22, 2022, 07:26 AM |
Davis John E | Senior VP, Global Sales | Feb 17, 2022 | Option Exercise | $17.50 | 2,035 | 35,613 | 81,319 | Feb 22, 2022, 07:24 AM |
GREEN ANDREW M | VP Regulatory | Feb 17, 2022 | Option Exercise | $17.50 | 576 | 10,080 | 1,051 | Feb 22, 2022, 07:23 AM |
Barthold Franz Peter | VP, Research & Development | Feb 17, 2022 | Option Exercise | $17.50 | 1,757 | 30,748 | 16,246 | Feb 22, 2022, 07:22 AM |
Mackin James P | President & CEO | Feb 09, 2022 | Option Exercise | $11.00 | 10,638 | 117,018 | 314,816 | Feb 11, 2022, 08:41 AM |
Mackin James P | President & CEO | Feb 10, 2022 | Option Exercise | $11.00 | 10,639 | 117,029 | 314,817 | Feb 11, 2022, 08:41 AM |
Mackin James P | President & CEO | Feb 10, 2022 | Sale | $17.86 | 10,639 | 189,998 | 304,178 | Feb 11, 2022, 08:41 AM |
Mackin James P | President & CEO | Feb 09, 2022 | Sale | $18.14 | 10,638 | 192,989 | 304,178 | Feb 11, 2022, 08:41 AM |
Mackin James P | President & CEO | Feb 08, 2022 | Option Exercise | $11.00 | 10,638 | 117,018 | 314,816 | Feb 10, 2022, 07:53 AM |
Mackin James P | President & CEO | Feb 08, 2022 | Sale | $17.75 | 10,638 | 188,771 | 304,178 | Feb 10, 2022, 07:53 AM |
Mackin James P | President & CEO | Feb 07, 2022 | Option Exercise | $11.00 | 10,638 | 117,018 | 314,816 | Feb 08, 2022, 04:38 PM |
Mackin James P | President & CEO | Feb 07, 2022 | Sale | $17.30 | 10,638 | 184,052 | 304,178 | Feb 08, 2022, 04:38 PM |
Horton Amy | VP, Chief Accounting Officer | Dec 09, 2021 | Option Exercise | $18.82 | 1,500 | 28,230 | 85,282 | Dec 10, 2021, 04:13 PM |
Horton Amy | VP, Chief Accounting Officer | Dec 08, 2021 | Sale | $18.57 | 2,500 | 46,422 | 86,782 | Dec 10, 2021, 04:13 PM |
Davis John E | Senior VP, Global Sales | Nov 29, 2021 | Buy | $17.33 | 600 | 10,398 | 72,499 | Dec 01, 2021, 04:14 PM |
SEMEDO ANTHONY B. | Director | Nov 29, 2021 | Option Exercise | $17.36 | 4,992 | 86,661 | 4,992 | Nov 30, 2021, 04:40 PM |
SEMEDO ANTHONY B. | Director | Nov 29, 2021 | Buy | $17.36 | 15,000 | 260,400 | 19,992 | Nov 30, 2021, 04:40 PM |
Maney Rochelle L. | VP, Quality | Nov 04, 2021 | Option Exercise | $21.21 | 214 | 4,539 | 14,108 | Nov 05, 2021, 04:30 PM |
Holloway Jean F | SVP, General Counsel | Aug 31, 2021 | Sale | $26.49 | 663 | 17,566 | 86,567 | Sep 01, 2021, 04:14 PM |
McCall Ronald D | Director | Aug 25, 2021 | Sale | $25.63 | 5,667 | 145,266 | 121,768 | Aug 26, 2021, 04:13 PM |
Maier Dennis B | Vice President, Operations | Aug 23, 2021 | Sale | $25.64 | 2,715 | 69,613 | 17,677 | Aug 24, 2021, 05:15 PM |
McCall Ronald D | Director | Jun 01, 2021 | Option Exercise | $29.39 | 4,423 | 129,992 | 127,435 | Jun 02, 2021, 04:25 PM |
Davis John E | Senior VP, Global Sales | May 25, 2021 | Option Exercise | $26.24 | 5,402 | 141,748 | 84,638 | May 27, 2021, 05:02 PM |
Davis John E | Senior VP, Global Sales | May 25, 2021 | Sale | $29.66 | 12,739 | 377,880 | 79,236 | May 27, 2021, 05:02 PM |
Horton Amy | VP, Chief Accounting Officer | May 06, 2021 | Option Exercise | $11.00 | 5,731 | 63,041 | 95,013 | May 10, 2021, 08:29 AM |
Horton Amy | VP, Chief Accounting Officer | May 06, 2021 | Sale | $30.00 | 5,731 | 171,930 | 89,282 | May 10, 2021, 08:29 AM |
Holloway Jean F | SVP, General Counsel | May 06, 2021 | Option Exercise | $10.24 | 6,618 | 67,768 | 93,848 | May 10, 2021, 08:28 AM |
Holloway Jean F | SVP, General Counsel | May 06, 2021 | Sale | $30.50 | 6,618 | 201,849 | 87,230 | May 10, 2021, 08:28 AM |
Maier Dennis B | Vice President, Operations | Mar 12, 2021 | Option Exercise | $25.05 | 1,385 | 34,694 | 21,172 | Mar 15, 2021, 04:29 PM |
Mackin James P | President & CEO | Mar 12, 2021 | Option Exercise | $25.05 | 15,766 | 394,938 | 306,852 | Mar 15, 2021, 04:29 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 12, 2021 | Option Exercise | $25.05 | 3,074 | 77,004 | 293,198 | Mar 15, 2021, 04:27 PM |
Horton Amy | VP, Chief Accounting Officer | Mar 12, 2021 | Option Exercise | $25.05 | 1,739 | 43,562 | 89,573 | Mar 15, 2021, 04:25 PM |
Holloway Jean F | SVP, General Counsel | Mar 12, 2021 | Option Exercise | $25.05 | 2,682 | 67,184 | 87,677 | Mar 15, 2021, 04:24 PM |
Davis John E | Senior VP, Global Sales | Mar 12, 2021 | Option Exercise | $25.05 | 2,236 | 56,012 | 79,609 | Mar 15, 2021, 04:21 PM |
Capps Scott B | VP, Clinical Research | Mar 12, 2021 | Option Exercise | $25.05 | 1,393 | 34,895 | 153,436 | Mar 15, 2021, 04:19 PM |
Holloway Jean F | SVP, General Counsel | Mar 10, 2021 | Sale | $25.28 | 1,693 | 42,797 | 89,912 | Mar 11, 2021, 04:20 PM |
Barthold Franz Peter | VP, Research & Development | Mar 08, 2021 | Option Exercise | $24.30 | 76 | 1,847 | 12,121 | Mar 10, 2021, 04:07 PM |
Simpson Michael S | SVP, Regulatory Affairs and QA | Mar 05, 2021 | Option Exercise | $24.44 | 304 | 7,430 | 33,698 | Mar 10, 2021, 07:51 AM |
Maier Dennis B | Vice President, Operations | Mar 05, 2021 | Option Exercise | $24.44 | 205 | 5,010 | 22,324 | Mar 10, 2021, 07:46 AM |
Mackin James P | President & CEO | Mar 05, 2021 | Option Exercise | $24.44 | 1,487 | 36,342 | 319,944 | Mar 10, 2021, 07:44 AM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 05, 2021 | Option Exercise | $24.44 | 359 | 8,774 | 295,759 | Mar 10, 2021, 07:43 AM |
Horton Amy | VP, Chief Accounting Officer | Mar 05, 2021 | Option Exercise | $24.44 | 226 | 5,523 | 91,021 | Mar 10, 2021, 07:39 AM |
Holloway Jean F | SVP, General Counsel | Mar 05, 2021 | Option Exercise | $24.44 | 299 | 7,308 | 91,605 | Mar 10, 2021, 07:34 AM |
Davis John E | Senior VP, Global Sales | Mar 05, 2021 | Option Exercise | $24.44 | 315 | 7,699 | 81,472 | Mar 10, 2021, 07:31 AM |
Capps Scott B | VP, Clinical Research | Mar 05, 2021 | Option Exercise | $24.44 | 205 | 5,010 | 154,596 | Mar 10, 2021, 07:28 AM |
Barthold Franz Peter | VP, Research & Development | Mar 05, 2021 | Option Exercise | $24.44 | 103 | 2,517 | 12,197 | Mar 10, 2021, 07:27 AM |
Horton Amy | VP, Chief Accounting Officer | Mar 01, 2021 | Sale | $25.53 | 13,619 | 347,711 | 91,247 | Mar 02, 2021, 04:41 PM |
Simpson Michael S | SVP, Regulatory Affairs and QA | Feb 23, 2021 | Option Exercise | $25.41 | 900 | 22,869 | 34,002 | Feb 25, 2021, 05:59 PM |
Maier Dennis B | Vice President, Operations | Feb 23, 2021 | Option Exercise | $25.41 | 563 | 14,306 | 22,529 | Feb 25, 2021, 05:58 PM |
Mackin James P | President & CEO | Feb 23, 2021 | Option Exercise | $25.41 | 4,383 | 111,372 | 321,431 | Feb 25, 2021, 05:56 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 23, 2021 | Option Exercise | $25.41 | 1,237 | 31,432 | 296,118 | Feb 25, 2021, 05:55 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 23, 2021 | Option Exercise | $25.41 | 619 | 15,729 | 104,866 | Feb 25, 2021, 05:53 PM |
Holloway Jean F | VP, General Counsel | Feb 23, 2021 | Option Exercise | $25.41 | 990 | 25,156 | 91,904 | Feb 25, 2021, 05:49 PM |
Getz Matthew A | VP, Human Resources | Feb 23, 2021 | Option Exercise | $25.41 | 563 | 14,306 | 9,514 | Feb 25, 2021, 05:47 PM |
Davis John E | Senior VP, Global Sales | Feb 23, 2021 | Option Exercise | $25.41 | 945 | 24,012 | 81,787 | Feb 25, 2021, 05:44 PM |
Capps Scott B | VP, Clinical Research | Feb 23, 2021 | Option Exercise | $25.41 | 563 | 14,306 | 154,801 | Feb 25, 2021, 05:42 PM |
Barthold Franz Peter | VP, Research & Development | Feb 23, 2021 | Option Exercise | $25.41 | 704 | 17,889 | 12,300 | Feb 25, 2021, 05:41 PM |
Maier Dennis B | Vice President, Operations | Feb 17, 2021 | Option Exercise | $21.55 | 6,630 | 142,876 | 23,211 | Feb 19, 2021, 04:28 PM |
Maier Dennis B | Vice President, Operations | Feb 17, 2021 | Sale | $24.73 | 7,197 | 177,956 | 16,581 | Feb 19, 2021, 04:28 PM |
Capps Scott B | VP, Clinical Research | Dec 15, 2020 | Option Exercise | $9.97 | 10,000 | 99,700 | 157,006 | Dec 16, 2020, 04:27 PM |
Capps Scott B | VP, Clinical Research | Dec 15, 2020 | Sale | $21.34 | 8,366 | 178,553 | 148,640 | Dec 16, 2020, 04:27 PM |
Horton Amy | VP, Chief Accounting Officer | Dec 14, 2020 | Option Exercise | $21.25 | 1,375 | 29,219 | 98,267 | Dec 16, 2020, 08:39 AM |
Horton Amy | VP, Chief Accounting Officer | Dec 14, 2020 | Option Exercise | $9.97 | 6,666 | 66,460 | 99,642 | Dec 16, 2020, 08:39 AM |
McCall Ronald D | Director | Dec 14, 2020 | Sale | $21.79 | 4,638 | 101,069 | 128,795 | Dec 15, 2020, 04:38 PM |
Maier Dennis B | Vice President, Operations | Dec 14, 2020 | Sale | $21.85 | 1,843 | 40,270 | 16,240 | Dec 15, 2020, 04:37 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Dec 10, 2020 | Option Exercise | $9.97 | 16,666 | 166,160 | 299,233 | Dec 14, 2020, 04:27 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Dec 10, 2020 | Sale | $23.00 | 16,666 | 383,318 | 282,567 | Dec 14, 2020, 04:27 PM |
Barthold Franz Peter | VP, Research & Development | Dec 01, 2020 | Option Exercise | $20.93 | 654 | 13,688 | 6,280 | Dec 03, 2020, 04:31 PM |
Horton Amy | VP, Chief Accounting Officer | Dec 01, 2020 | Option Exercise | $9.97 | 6,666 | 66,460 | 99,642 | Dec 02, 2020, 04:59 PM |
Horton Amy | VP, Chief Accounting Officer | Dec 01, 2020 | Sale | $20.78 | 6,666 | 138,503 | 92,976 | Dec 02, 2020, 04:59 PM |
Maier Dennis B | Vice President, Operations | Nov 02, 2020 | Option Exercise | $17.62 | 1,585 | 27,928 | 18,083 | Nov 04, 2020, 05:06 PM |
Mackin James P | President & CEO | Sep 16, 2020 | Buy | $16.74 | 7,500 | 125,524 | 264,274 | Oct 01, 2020, 09:00 AM |
Davis John E | Senior VP, Global Sales | Sep 16, 2020 | Buy | $16.65 | 10,000 | 166,459 | 70,451 | Sep 17, 2020, 05:53 PM |
Bullock James | Director | Sep 16, 2020 | Buy | $16.63 | 10,000 | 166,273 | 34,023 | Sep 17, 2020, 05:50 PM |
Mackin James P | President & CEO | Sep 16, 2020 | Option Exercise | $16.74 | 7,500 | 125,524 | 264,274 | Sep 16, 2020, 01:23 PM |
Salveson Jon W | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 95,216 | Jun 02, 2020, 04:50 PM |
MORGAN HARVEY | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 52,070 | Jun 02, 2020, 04:49 PM |
McCall Ronald D | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 133,433 | Jun 02, 2020, 04:47 PM |
Burbank Jeffrey H | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 19,172 | Jun 02, 2020, 04:45 PM |
Bullock James | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 24,023 | Jun 02, 2020, 04:44 PM |
Borgstrom Marna P | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 14,464 | Jun 02, 2020, 04:42 PM |
BEVEVINO DANIEL J | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 115,437 | Jun 02, 2020, 04:41 PM |
ACKERMAN THOMAS F | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 115,272 | Jun 02, 2020, 04:38 PM |
Horton Amy | VP, Chief Accounting Officer | May 28, 2020 | Sale | $23.81 | 3,000 | 71,415 | 99,642 | May 29, 2020, 08:06 AM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | May 22, 2020 | Option Exercise | $22.86 | 125 | 2,858 | 282,567 | May 27, 2020, 05:50 PM |
McCall Ronald D | Director | May 05, 2020 | Sale | $22.82 | 1,719 | 39,219 | 127,766 | May 07, 2020, 05:14 PM |
Maier Dennis B | Vice President, Operations | Mar 12, 2020 | Option Exercise | $20.24 | 226 | 4,574 | 19,668 | Mar 16, 2020, 07:53 AM |
Mackin James P | President & CEO | Mar 12, 2020 | Option Exercise | $20.24 | 2,674 | 54,122 | 256,774 | Mar 16, 2020, 07:52 AM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 12, 2020 | Option Exercise | $20.24 | 513 | 10,383 | 282,692 | Mar 16, 2020, 07:50 AM |
Horton Amy | VP, Chief Accounting Officer | Mar 12, 2020 | Option Exercise | $20.24 | 292 | 5,910 | 102,642 | Mar 16, 2020, 07:48 AM |
Holloway Jean F | VP, General Counsel | Mar 12, 2020 | Option Exercise | $20.24 | 447 | 9,047 | 65,051 | Mar 16, 2020, 07:46 AM |
Davis John E | Senior VP, Global Sales | Mar 12, 2020 | Option Exercise | $20.24 | 373 | 7,550 | 60,451 | Mar 16, 2020, 07:43 AM |
Capps Scott B | VP, Clinical Research | Mar 12, 2020 | Option Exercise | $20.24 | 233 | 4,716 | 147,006 | Mar 16, 2020, 07:38 AM |
Bogenschuetz Thomas J | VP, EMEA & General Manager | Mar 12, 2020 | Option Exercise | $20.24 | 337 | 6,821 | 23,451 | Mar 16, 2020, 07:37 AM |
Simpson Michael S | SVP, Regulatory Affairs and QA | Mar 05, 2020 | Option Exercise | $24.93 | 658 | 16,404 | 24,387 | Mar 09, 2020, 04:18 PM |
Maier Dennis B | Vice President, Operations | Mar 05, 2020 | Option Exercise | $24.93 | 411 | 10,246 | 19,894 | Mar 09, 2020, 04:15 PM |
Mackin James P | President & CEO | Mar 05, 2020 | Option Exercise | $24.93 | 4,455 | 111,063 | 273,448 | Mar 09, 2020, 04:14 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 05, 2020 | Option Exercise | $24.93 | 734 | 18,299 | 287,305 | Mar 09, 2020, 04:13 PM |
Horton Amy | VP, Chief Accounting Officer | Mar 05, 2020 | Option Exercise | $24.93 | 385 | 9,598 | 105,234 | Mar 09, 2020, 04:11 PM |
Holloway Jean F | VP, General Counsel | Mar 05, 2020 | Option Exercise | $24.93 | 615 | 15,332 | 68,888 | Mar 09, 2020, 04:10 PM |
Davis John E | Senior VP, Global Sales | Mar 05, 2020 | Option Exercise | $24.93 | 615 | 15,332 | 64,072 | Mar 09, 2020, 04:08 PM |
Capps Scott B | VP, Clinical Research | Mar 05, 2020 | Option Exercise | $24.93 | 350 | 8,726 | 149,237 | Mar 09, 2020, 04:07 PM |
Bogenschuetz Thomas J | VP, EMEA & General Manager | Mar 05, 2020 | Option Exercise | $24.93 | 911 | 22,711 | 23,788 | Mar 09, 2020, 04:05 PM |
McCall Ronald D | Director | Feb 24, 2020 | Sale | $26.05 | 4,734 | 123,340 | 127,865 | Feb 25, 2020, 04:38 PM |
Mackin James P | President & CEO | Feb 21, 2020 | Option Exercise | $26.20 | 9,999 | 261,974 | 258,147 | Feb 25, 2020, 04:37 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 21, 2020 | Option Exercise | $26.20 | 2,057 | 53,893 | 103,065 | Feb 25, 2020, 04:34 PM |
Holloway Jean F | VP, General Counsel | Feb 21, 2020 | Option Exercise | $26.20 | 2,780 | 72,836 | 65,419 | Feb 25, 2020, 04:33 PM |
Davis John E | Senior VP, Global Sales | Feb 21, 2020 | Option Exercise | $26.20 | 2,817 | 73,805 | 60,603 | Feb 25, 2020, 04:31 PM |
Capps Scott B | VP, Clinical Research | Feb 21, 2020 | Option Exercise | $26.20 | 1,802 | 47,212 | 147,267 | Feb 25, 2020, 04:30 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 21, 2020 | Option Exercise | $26.20 | 3,487 | 91,359 | 283,165 | Feb 25, 2020, 12:00 AM |
Holloway Jean F | VP, General Counsel | Jan 21, 2020 | Option Exercise | $9.64 | 8,458 | 81,535 | 67,322 | Jan 23, 2020, 04:13 PM |
Holloway Jean F | VP, General Counsel | Jan 21, 2020 | Sale | $30.00 | 8,458 | 253,744 | 58,864 | Jan 23, 2020, 04:13 PM |
Holloway Jean F | VP, General Counsel | Jan 16, 2020 | Option Exercise | $9.64 | 195 | 1,880 | 59,059 | Jan 21, 2020, 04:28 PM |
Holloway Jean F | VP, General Counsel | Jan 16, 2020 | Sale | $30.00 | 195 | 5,850 | 58,864 | Jan 21, 2020, 04:28 PM |
Holloway Jean F | VP, General Counsel | Dec 12, 2019 | Option Exercise | $10.24 | 3,000 | 30,720 | 61,864 | Dec 13, 2019, 04:16 PM |
Holloway Jean F | VP, General Counsel | Dec 12, 2019 | Sale | $26.00 | 3,000 | 78,000 | 58,864 | Dec 13, 2019, 04:16 PM |
Capps Scott B | VP, Clinical Research | Nov 26, 2019 | Option Exercise | $6.12 | 10,000 | 61,200 | 151,079 | Nov 27, 2019, 04:13 PM |
Capps Scott B | VP, Clinical Research | Nov 26, 2019 | Sale | $24.93 | 7,184 | 179,108 | 143,895 | Nov 27, 2019, 04:13 PM |
McCall Ronald D | Director | Nov 19, 2019 | Sale | $24.64 | 4,000 | 98,565 | 132,599 | Nov 19, 2019, 04:43 PM |
Mackin James P | President & CEO | Nov 13, 2019 | Buy | $23.47 | 5,000 | 117,355 | 225,731 | Nov 13, 2019, 04:14 PM |
MORGAN HARVEY | Director | Nov 06, 2019 | Option Exercise | $23.06 | 2,319 | 53,476 | 44,783 | Nov 07, 2019, 04:32 PM |
Horton Amy | VP, Chief Accounting Officer | Jun 05, 2019 | Option Exercise | $29.17 | 1,000 | 29,170 | 99,329 | Jun 06, 2019, 04:48 PM |
Capps Scott B | VP, Clinical Research | May 31, 2019 | Sale | $28.55 | 2,000 | 57,100 | 141,079 | Jun 03, 2019, 04:31 PM |
McCall Ronald D | Director | May 24, 2019 | Sale | $28.47 | 1,563 | 44,499 | 136,599 | May 29, 2019, 04:16 PM |
McCall Ronald D | Director | May 22, 2019 | Sale | $29.02 | 2,700 | 78,346 | 139,162 | May 24, 2019, 04:18 PM |
McCall Ronald D | Director | May 23, 2019 | Sale | $28.00 | 1,000 | 28,000 | 138,162 | May 24, 2019, 04:18 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | May 13, 2019 | Option Exercise | $29.88 | 90 | 2,689 | 275,565 | May 14, 2019, 08:34 PM |
Mackin James P | President & CEO | May 03, 2019 | Sale | $31.31 | 50,000 | 1,565,690 | 220,731 | May 07, 2019, 04:53 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | May 03, 2019 | Option Exercise | $6.12 | 16,666 | 101,996 | 300,910 | May 07, 2019, 04:48 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | May 03, 2019 | Sale | $31.36 | 25,255 | 791,959 | 284,244 | May 07, 2019, 04:48 PM |
Holloway Jean F | VP, General Counsel | May 06, 2019 | Option Exercise | $9.64 | 8,654 | 83,425 | 67,020 | May 07, 2019, 04:47 PM |
Holloway Jean F | VP, General Counsel | May 06, 2019 | Sale | $32.00 | 8,654 | 276,928 | 58,366 | May 07, 2019, 04:47 PM |
Holloway Jean F | VP, General Counsel | May 01, 2019 | Option Exercise | $10.24 | 10,000 | 102,400 | 68,366 | May 03, 2019, 07:29 PM |
Holloway Jean F | VP, General Counsel | May 01, 2019 | Sale | $31.50 | 10,000 | 315,000 | 58,366 | May 03, 2019, 07:29 PM |
Saurini Sherry M | VP, Quality | Mar 14, 2019 | Option Exercise | $29.82 | 466 | 13,896 | 25,084 | Mar 18, 2019, 05:02 PM |
McDermid James M | SVP, CHRO | Mar 14, 2019 | Option Exercise | $29.82 | 745 | 22,216 | 30,806 | Mar 18, 2019, 05:01 PM |
Maier Dennis B | Vice President, Operations | Mar 14, 2019 | Option Exercise | $29.82 | 452 | 13,479 | 14,583 | Mar 18, 2019, 04:59 PM |
Mackin James P | President & CEO | Mar 14, 2019 | Option Exercise | $29.82 | 5,237 | 156,165 | 270,731 | Mar 18, 2019, 04:58 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 14, 2019 | Option Exercise | $28.92 | 1,029 | 29,762 | 284,244 | Mar 18, 2019, 04:57 PM |
Horton Amy | VP, Chief Accounting Officer | Mar 14, 2019 | Option Exercise | $28.92 | 584 | 16,891 | 100,329 | Mar 18, 2019, 04:55 PM |
Holloway Jean F | VP, General Counsel | Mar 14, 2019 | Option Exercise | $28.92 | 897 | 25,944 | 58,366 | Mar 18, 2019, 04:54 PM |
Davis John E | Senior VP, Global Sales | Mar 14, 2019 | Option Exercise | $28.92 | 748 | 21,635 | 53,957 | Mar 18, 2019, 04:52 PM |
Capps Scott B | VP, Clinical Research | Mar 14, 2019 | Option Exercise | $28.92 | 468 | 13,536 | 143,079 | Mar 18, 2019, 04:51 PM |
Bogenschuetz Thomas J | VP, EMEA & General Manager | Mar 14, 2019 | Option Exercise | $28.92 | 735 | 21,256 | 20,615 | Mar 18, 2019, 04:48 PM |
Horton Amy | VP, Chief Accounting Officer | Mar 06, 2019 | Option Exercise | $6.12 | 6,666 | 40,796 | 103,713 | Mar 08, 2019, 06:10 PM |
Horton Amy | VP, Chief Accounting Officer | Mar 06, 2019 | Sale | $29.15 | 6,666 | 194,299 | 97,047 | Mar 08, 2019, 06:10 PM |
Saurini Sherry M | VP, Quality | Mar 02, 2019 | Option Exercise | $29.70 | 1,388 | 41,224 | 22,460 | Mar 07, 2019, 09:44 PM |
Saurini Sherry M | VP, Quality | Mar 01, 2019 | Option Exercise | $29.70 | 778 | 23,107 | 23,848 | Mar 04, 2019, 08:26 AM |
McDermid James M | SVP, CHRO | Mar 01, 2019 | Option Exercise | $29.70 | 501 | 14,880 | 22,102 | Mar 04, 2019, 08:22 AM |
Mackin James P | President & CEO | Mar 01, 2019 | Option Exercise | $29.70 | 8,103 | 240,659 | 228,593 | Mar 04, 2019, 08:19 AM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 01, 2019 | Option Exercise | $29.70 | 2,015 | 59,846 | 272,561 | Mar 04, 2019, 08:17 AM |
Horton Amy | VP, Chief Accounting Officer | Mar 01, 2019 | Option Exercise | $29.70 | 1,133 | 33,650 | 93,952 | Mar 04, 2019, 08:13 AM |
Holloway Jean F | VP, General Counsel | Mar 01, 2019 | Option Exercise | $29.70 | 1,506 | 44,728 | 48,371 | Mar 04, 2019, 08:08 AM |
Davis John E | Senior VP, Global Sales | Mar 01, 2019 | Option Exercise | $29.70 | 1,485 | 44,105 | 44,805 | Mar 04, 2019, 08:05 AM |
Capps Scott B | VP, Clinical Research | Mar 01, 2019 | Option Exercise | $29.70 | 1,087 | 32,284 | 137,642 | Mar 04, 2019, 08:03 AM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 22, 2019 | Option Exercise | $29.38 | 1,103 | 32,406 | 274,576 | Feb 25, 2019, 07:53 PM |
McCall Ronald D | Director | Feb 21, 2019 | Sale | $29.26 | 6,200 | 181,390 | 137,699 | Feb 25, 2019, 07:52 PM |
Holloway Jean F | VP, General Counsel | Feb 22, 2019 | Option Exercise | $29.38 | 882 | 25,913 | 49,877 | Feb 25, 2019, 07:51 PM |
Saurini Sherry M | VP, Quality | Feb 19, 2019 | Option Exercise | $28.84 | 1,760 | 50,758 | 24,626 | Feb 21, 2019, 05:30 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 19, 2019 | Option Exercise | $28.84 | 2,368 | 68,293 | 95,085 | Feb 21, 2019, 05:29 PM |
Capps Scott B | VP, Clinical Research | Feb 19, 2019 | Option Exercise | $28.84 | 2,358 | 68,005 | 138,729 | Feb 21, 2019, 05:28 PM |
Davis John E | Senior VP, Global Sales | Feb 19, 2019 | Option Exercise | $28.84 | 2,941 | 84,818 | 46,290 | Feb 21, 2019, 05:27 PM |
Holloway Jean F | VP, General Counsel | Feb 19, 2019 | Option Exercise | $28.84 | 2,933 | 84,588 | 50,759 | Feb 21, 2019, 05:26 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2019 | Option Exercise | $28.84 | 4,053 | 116,889 | 275,679 | Feb 21, 2019, 05:25 PM |
Mackin James P | President & CEO | Feb 19, 2019 | Option Exercise | $28.84 | 6,602 | 190,402 | 236,696 | Feb 21, 2019, 05:24 PM |
Davis John E | Senior VP, Global Sales | Sep 18, 2018 | Option Exercise | $9.64 | 3,333 | 32,130 | 52,564 | Sep 20, 2018, 05:02 PM |
Davis John E | Senior VP, Global Sales | Sep 18, 2018 | Sale | $33.86 | 3,333 | 112,843 | 49,231 | Sep 20, 2018, 05:02 PM |
Davis John E | Senior VP, Global Sales | Sep 10, 2018 | Option Exercise | $34.00 | 3,512 | 119,408 | 49,231 | Sep 12, 2018, 04:50 PM |
Holloway Jean F | VP, General Counsel | Sep 10, 2018 | Option Exercise | $34.00 | 2,201 | 74,834 | 53,385 | Sep 12, 2018, 12:00 AM |
RONALD C ELKINS | Director | Sep 05, 2018 | Sale | $34.53 | 5,000 | 172,672 | 64,843 | Sep 06, 2018, 04:21 PM |
Capps Scott B | VP, Clinical Research | Aug 30, 2018 | Option Exercise | $5.67 | 8,332 | 47,242 | 147,419 | Sep 04, 2018, 06:59 PM |
Capps Scott B | VP, Clinical Research | Aug 30, 2018 | Sale | $34.10 | 6,332 | 215,921 | 141,087 | Sep 04, 2018, 06:59 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 15, 2018 | Option Exercise | $5.67 | 16,666 | 94,496 | 296,398 | Aug 16, 2018, 05:24 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 15, 2018 | Sale | $31.92 | 16,666 | 531,994 | 279,732 | Aug 16, 2018, 05:24 PM |
MORGAN HARVEY | Director | Aug 14, 2018 | Sale | $32.66 | 2,369 | 77,373 | 38,298 | Aug 15, 2018, 05:49 PM |
MORGAN HARVEY | Director | Aug 14, 2018 | Sale | $32.66 | 2,443 | 79,776 | 42,939 | Aug 15, 2018, 05:49 PM |
MORGAN HARVEY | Director | Aug 13, 2018 | Sale | $32.44 | 5,188 | 168,283 | 45,382 | Aug 15, 2018, 05:49 PM |
Mackin James P | President & CEO | Aug 13, 2018 | Option Exercise | $10.24 | 103,072 | 1,055,457 | 380,970 | Aug 15, 2018, 05:48 PM |
Mackin James P | President & CEO | Aug 15, 2018 | Option Exercise | $10.24 | 9,851 | 100,874 | 287,749 | Aug 15, 2018, 05:48 PM |
Mackin James P | President & CEO | Aug 14, 2018 | Option Exercise | $10.24 | 37,077 | 379,668 | 314,975 | Aug 15, 2018, 05:48 PM |
Mackin James P | President & CEO | Aug 13, 2018 | Sale | $32.17 | 103,072 | 3,315,950 | 277,898 | Aug 15, 2018, 05:48 PM |
Mackin James P | President & CEO | Aug 15, 2018 | Sale | $31.79 | 9,851 | 313,209 | 277,898 | Aug 15, 2018, 05:48 PM |
Mackin James P | President & CEO | Aug 14, 2018 | Sale | $32.22 | 37,077 | 1,194,473 | 277,898 | Aug 15, 2018, 05:48 PM |
Mackin James P | President & CEO | Aug 10, 2018 | Sale | $33.32 | 42,675 | 1,421,968 | 297,050 | Aug 13, 2018, 04:43 PM |
McCall Ronald D | Director | Aug 09, 2018 | Sale | $32.69 | 2,750 | 89,900 | 143,899 | Aug 13, 2018, 04:39 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 10, 2018 | Sale | $32.98 | 10,247 | 337,924 | 279,732 | Aug 13, 2018, 04:37 PM |
Horton Amy | VP, Chief Accounting Officer | Aug 10, 2018 | Sale | $32.85 | 3,000 | 98,550 | 97,453 | Aug 13, 2018, 04:35 PM |
Holloway Jean F | VP, General Counsel | Aug 10, 2018 | Option Exercise | $10.28 | 1,500 | 15,420 | 60,235 | Aug 13, 2018, 04:34 PM |
Holloway Jean F | VP, General Counsel | Aug 10, 2018 | Sale | $33.50 | 1,500 | 50,250 | 58,735 | Aug 13, 2018, 04:34 PM |
RONALD C ELKINS | Director | Aug 10, 2018 | Sale | $33.27 | 1,154 | 38,393 | 69,843 | Aug 13, 2018, 04:31 PM |
Holloway Jean F | VP, General Counsel | Aug 07, 2018 | Option Exercise | $10.28 | 4,000 | 41,120 | 62,735 | Aug 09, 2018, 05:27 PM |
Holloway Jean F | VP, General Counsel | Aug 07, 2018 | Sale | $32.50 | 4,000 | 130,000 | 58,735 | Aug 09, 2018, 05:27 PM |
Davis John E | Senior VP, Global Sales | Jul 26, 2018 | Option Exercise | $16.30 | 3,391 | 55,273 | 56,134 | Jul 30, 2018, 04:32 PM |
Davis John E | Senior VP, Global Sales | Jul 26, 2018 | Sale | $31.00 | 3,391 | 105,121 | 52,743 | Jul 30, 2018, 04:32 PM |
Holloway Jean F | VP, General Counsel | Jul 23, 2018 | Option Exercise | $10.28 | 1,500 | 15,420 | 60,235 | Jul 25, 2018, 04:44 PM |
Holloway Jean F | VP, General Counsel | Jul 23, 2018 | Sale | $30.50 | 1,500 | 45,750 | 58,735 | Jul 25, 2018, 04:44 PM |
Saurini Sherry M | VP, Quality | Jan 01, 2018 | Option Exercise | $16.24 | 191 | 3,101 | 26,274 | Jul 10, 2018, 04:49 PM |
McDermid James M | SVP, CHRO | Jan 01, 2018 | Option Exercise | $16.24 | 1,179 | 19,141 | 22,518 | Jul 10, 2018, 04:47 PM |
Holloway Jean F | VP, General Counsel | Jan 01, 2018 | Option Exercise | $16.24 | 861 | 13,978 | 58,738 | Jul 10, 2018, 04:46 PM |
Davis John E | Senior VP, Global Sales | Jul 06, 2018 | Option Exercise | $16.30 | 3,391 | 55,273 | 56,137 | Jul 10, 2018, 04:43 PM |
Davis John E | Senior VP, Global Sales | Jan 01, 2018 | Option Exercise | $16.24 | 1,308 | 21,235 | 52,746 | Jul 10, 2018, 04:43 PM |
Davis John E | Senior VP, Global Sales | Jul 06, 2018 | Sale | $30.00 | 3,391 | 101,730 | 52,746 | Jul 10, 2018, 04:43 PM |
Davis John E | Senior VP, Global Sales | Jun 14, 2018 | Option Exercise | $29.00 | 4,372 | 126,788 | 51,438 | Jun 15, 2018, 05:19 PM |
Davis John E | Senior VP, Global Sales | Jun 14, 2018 | Option Exercise | $10.24 | 4,372 | 44,769 | 55,810 | Jun 15, 2018, 05:19 PM |
RONALD C ELKINS | Director | Jun 14, 2018 | Sale | $28.89 | 5,000 | 144,446 | 70,997 | Jun 15, 2018, 05:17 PM |
Horton Amy | VP, Chief Accounting Officer | Jun 01, 2018 | Option Exercise | $5.67 | 5,000 | 28,350 | 102,709 | Jun 05, 2018, 04:23 PM |
Horton Amy | VP, Chief Accounting Officer | Jun 01, 2018 | Sale | $28.00 | 2,256 | 63,168 | 100,453 | Jun 05, 2018, 04:23 PM |
Davis John E | Senior VP, Global Sales | Jun 01, 2018 | Option Exercise | $10.24 | 4,373 | 44,780 | 55,811 | Jun 05, 2018, 04:22 PM |
Davis John E | Senior VP, Global Sales | Jun 01, 2018 | Sale | $28.00 | 4,373 | 122,444 | 51,438 | Jun 05, 2018, 04:22 PM |
RONALD C ELKINS | Director | May 30, 2018 | Sale | $27.17 | 3,000 | 81,525 | 75,997 | Jun 01, 2018, 09:07 AM |
Davis John E | Senior VP, Global Sales | May 16, 2018 | Option Exercise | $10.24 | 4,373 | 44,780 | 55,811 | May 18, 2018, 04:32 PM |
Davis John E | Senior VP, Global Sales | May 16, 2018 | Sale | $27.00 | 4,373 | 118,071 | 51,438 | May 18, 2018, 04:32 PM |
RONALD C ELKINS | Director | May 14, 2018 | Sale | $24.75 | 10,000 | 247,500 | 78,997 | May 15, 2018, 05:32 PM |
McCall Ronald D | Director | May 08, 2018 | Sale | $25.95 | 260 | 6,747 | 142,011 | May 15, 2018, 05:30 PM |
McCall Ronald D | Director | May 10, 2018 | Sale | $25.39 | 2,000 | 50,782 | 142,271 | May 11, 2018, 05:23 PM |
McCall Ronald D | Director | May 09, 2018 | Sale | $25.67 | 2,240 | 57,494 | 144,271 | May 11, 2018, 05:23 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | May 10, 2018 | Option Exercise | $25.30 | 100 | 2,530 | 289,979 | May 11, 2018, 05:21 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | May 09, 2018 | Sale | $25.70 | 10,000 | 256,999 | 290,079 | May 11, 2018, 05:21 PM |
Horton Amy | VP, Chief Accounting Officer | May 09, 2018 | Option Exercise | $25.45 | 1,250 | 31,813 | 97,709 | May 11, 2018, 05:20 PM |
Horton Amy | VP, Chief Accounting Officer | May 09, 2018 | Sale | $25.94 | 4,000 | 103,764 | 98,959 | May 11, 2018, 05:20 PM |
Davis John E | Senior VP, Global Sales | May 08, 2018 | Option Exercise | $10.24 | 4,373 | 44,780 | 55,811 | May 10, 2018, 04:43 PM |
Davis John E | Senior VP, Global Sales | May 08, 2018 | Sale | $26.00 | 4,373 | 113,698 | 51,438 | May 10, 2018, 04:43 PM |
RONALD C ELKINS | Director | May 10, 2018 | Sale | $25.30 | 5,000 | 126,500 | 88,997 | May 10, 2018, 04:41 PM |
RONALD C ELKINS | Director | May 08, 2018 | Sale | $25.58 | 1,852 | 47,379 | 93,997 | May 10, 2018, 04:41 PM |
RONALD C ELKINS | Director | May 03, 2018 | Sale | $24.00 | 2,000 | 48,000 | 95,849 | May 08, 2018, 04:26 PM |
Davis John E | Senior VP, Global Sales | May 03, 2018 | Option Exercise | $9.64 | 3,334 | 32,140 | 54,772 | May 08, 2018, 04:24 PM |
Davis John E | Senior VP, Global Sales | May 03, 2018 | Sale | $24.00 | 3,334 | 80,016 | 51,438 | May 08, 2018, 04:24 PM |
Davis John E | Senior VP, Global Sales | Apr 17, 2018 | Option Exercise | $9.64 | 3,333 | 32,130 | 54,771 | Apr 18, 2018, 04:42 PM |
Davis John E | Senior VP, Global Sales | Apr 17, 2018 | Sale | $23.00 | 3,333 | 76,659 | 51,438 | Apr 18, 2018, 04:42 PM |
Holloway Jean F | VP, General Counsel | Apr 01, 2018 | Option Exercise | $20.05 | 2,125 | 42,606 | 57,877 | Apr 03, 2018, 08:58 AM |
Matthews William Robert | Senior VP, Operations, Quality | Mar 05, 2018 | Option Exercise | $19.15 | 886 | 16,967 | 39,883 | Mar 26, 2018, 04:31 PM |
McCall Ronald D | Director | Mar 08, 2018 | Sale | $21.09 | 5,000 | 105,448 | 146,511 | Mar 09, 2018, 04:51 PM |
RONALD C ELKINS | Director | Mar 08, 2018 | Sale | $22.00 | 2,000 | 44,000 | 97,849 | Mar 09, 2018, 04:51 PM |
Mackin James P | President & CEO | Mar 05, 2018 | Option Exercise | $19.15 | 6,349 | 121,583 | 320,933 | Mar 07, 2018, 05:26 PM |
McDermid James M | SVP, CHRO | Mar 05, 2018 | Option Exercise | $19.15 | 997 | 19,093 | 15,152 | Mar 07, 2018, 05:26 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 05, 2018 | Option Exercise | $19.15 | 1,245 | 23,842 | 291,572 | Mar 07, 2018, 05:26 PM |
Horton Amy | VP, Chief Accounting Officer | Mar 05, 2018 | Option Exercise | $19.15 | 698 | 13,367 | 98,125 | Mar 07, 2018, 05:26 PM |
Holloway Jean F | VP, General Counsel | Mar 05, 2018 | Option Exercise | $19.15 | 1,022 | 19,571 | 52,577 | Mar 07, 2018, 05:19 PM |
Davis John E | Senior VP, Global Sales | Mar 05, 2018 | Option Exercise | $19.15 | 957 | 18,327 | 45,251 | Mar 07, 2018, 05:19 PM |
Capps Scott B | VP, Clinical Research | Mar 05, 2018 | Option Exercise | $19.15 | 607 | 11,624 | 135,220 | Mar 07, 2018, 05:19 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2018 | Option Exercise | $18.25 | 3,744 | 68,328 | 284,617 | Feb 21, 2018, 07:50 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 19, 2018 | Option Exercise | $18.25 | 1,480 | 27,010 | 94,223 | Feb 21, 2018, 07:46 PM |
Capps Scott B | VP, Clinical Research | Feb 19, 2018 | Option Exercise | $18.25 | 2,246 | 40,990 | 131,827 | Feb 21, 2018, 07:44 PM |
Mackin James P | President & CEO | Feb 19, 2018 | Option Exercise | $18.25 | 9,527 | 173,868 | 299,282 | Feb 21, 2018, 07:44 PM |
Matthews William Robert | Senior VP, Operations, Quality | Feb 19, 2018 | Option Exercise | $18.25 | 1,183 | 21,590 | 35,117 | Feb 21, 2018, 05:26 PM |
Mackin James P | President & CEO | Feb 19, 2018 | Option Exercise | $18.25 | 7,640 | 139,430 | 313,400 | Feb 21, 2018, 05:23 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2018 | Option Exercise | $18.25 | 2,788 | 50,881 | 289,774 | Feb 21, 2018, 05:23 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 19, 2018 | Option Exercise | $18.25 | 1,502 | 27,412 | 96,636 | Feb 21, 2018, 05:20 PM |
Holloway Jean F | VP, General Counsel | Feb 19, 2018 | Option Exercise | $18.25 | 1,877 | 34,255 | 47,858 | Feb 21, 2018, 05:18 PM |
Davis John E | Senior VP, Global Sales | Feb 19, 2018 | Option Exercise | $18.25 | 1,183 | 21,590 | 39,708 | Feb 21, 2018, 05:16 PM |
Capps Scott B | VP, Clinical Research | Feb 19, 2018 | Option Exercise | $18.25 | 1,521 | 27,758 | 134,868 | Feb 21, 2018, 05:15 PM |
Capps Scott B | VP, Clinical Research | Feb 13, 2018 | Option Exercise | $17.10 | 9,381 | 160,415 | 104,261 | Feb 15, 2018, 05:28 PM |
Capps Scott B | VP, Clinical Research | Feb 13, 2018 | Option Exercise | $5.12 | 31,333 | 160,425 | 135,594 | Feb 15, 2018, 05:28 PM |
RONALD C ELKINS | Director | Dec 15, 2017 | Sale | $20.00 | 1,000 | 20,000 | 99,849 | Dec 19, 2017, 05:30 PM |
Gale David C | VP, Research & Development | Nov 16, 2017 | Option Exercise | $5.94 | 20,000 | 118,800 | 87,135 | Nov 17, 2017, 04:17 PM |
Gale David C | VP, Research & Development | Nov 16, 2017 | Sale | $19.63 | 20,000 | 392,500 | 77,135 | Nov 17, 2017, 04:17 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 08, 2017 | Option Exercise | $5.12 | 33,190 | 169,933 | 324,339 | Nov 13, 2017, 04:47 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 09, 2017 | Option Exercise | $5.12 | 30,143 | 154,332 | 321,292 | Nov 13, 2017, 04:47 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 08, 2017 | Sale | $19.00 | 33,190 | 630,550 | 291,149 | Nov 13, 2017, 04:47 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 09, 2017 | Sale | $18.57 | 30,143 | 559,888 | 291,149 | Nov 13, 2017, 04:47 PM |
Horton Amy | VP, Chief Accounting Officer | Nov 08, 2017 | Sale | $19.00 | 4,000 | 76,000 | 98,705 | Nov 13, 2017, 04:45 PM |
RONALD C ELKINS | Director | Nov 06, 2017 | Sale | $19.03 | 1,000 | 19,030 | 100,849 | Nov 08, 2017, 05:22 PM |
Benson James | Director | Oct 02, 2017 | Sale | $22.80 | 2,000 | 45,600 | 54,086 | Oct 04, 2017, 04:49 PM |
Mackin James P | President & CEO | Sep 06, 2017 | Sale | $21.97 | 81,950 | 1,800,679 | 316,449 | Sep 06, 2017, 05:43 PM |
Mackin James P | President & CEO | Sep 05, 2017 | Sale | $22.09 | 43,050 | 951,061 | 398,399 | Sep 06, 2017, 05:43 PM |
RONALD C ELKINS | Director | Sep 05, 2017 | Sale | $22.00 | 1,000 | 22,000 | 101,849 | Sep 06, 2017, 05:42 PM |
Benson James | Director | Jul 03, 2017 | Option Exercise | $19.95 | 2,000 | 39,900 | 56,086 | Jul 06, 2017, 05:03 PM |
Horton Amy | VP, Chief Accounting Officer | Jun 27, 2017 | Option Exercise | $5.12 | 18,667 | 95,575 | 112,282 | Jun 29, 2017, 09:19 AM |
Horton Amy | VP, Chief Accounting Officer | Jun 27, 2017 | Sale | $20.00 | 9,577 | 191,540 | 102,705 | Jun 29, 2017, 09:19 AM |
McCall Ronald D | Director | May 22, 2017 | Option Exercise | $18.28 | 7,000 | 127,938 | 151,511 | May 24, 2017, 09:21 AM |
Benson James | Director | Apr 03, 2017 | Option Exercise | $16.60 | 2,000 | 33,200 | 58,086 | Apr 10, 2017, 04:57 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 26, 2017 | Option Exercise | $17.25 | 278 | 4,796 | 93,615 | Feb 28, 2017, 05:33 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 26, 2017 | Option Exercise | $17.25 | 2,224 | 38,364 | 93,893 | Feb 28, 2017, 05:33 PM |
Gale David C | VP, Research & Development | Feb 26, 2017 | Option Exercise | $17.25 | 3,752 | 64,722 | 77,552 | Feb 28, 2017, 05:31 PM |
Capps Scott B | VP, Clinical Research | Feb 26, 2017 | Option Exercise | $17.25 | 3,752 | 64,722 | 114,059 | Feb 28, 2017, 05:28 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 26, 2017 | Option Exercise | $17.25 | 6,254 | 107,882 | 291,884 | Feb 28, 2017, 05:27 PM |
Capps Scott B | VP, Clinical Research | Feb 22, 2017 | Option Exercise | $7.01 | 16,667 | 116,836 | 128,477 | Feb 24, 2017, 09:10 AM |
Capps Scott B | VP, Clinical Research | Feb 22, 2017 | Sale | $16.40 | 11,083 | 181,776 | 117,394 | Feb 24, 2017, 09:10 AM |
Matthews William Robert | Senior VP, Operations, Quality | Feb 19, 2017 | Option Exercise | $17.25 | 13,262 | 228,770 | 32,232 | Feb 22, 2017, 07:00 PM |
Matthews William Robert | Senior VP, Operations, Quality | Feb 19, 2017 | Option Exercise | $17.25 | 2,212 | 38,157 | 30,020 | Feb 22, 2017, 07:00 PM |
Mackin James P | President & CEO | Feb 19, 2017 | Option Exercise | $17.25 | 60,496 | 1,043,556 | 425,705 | Feb 22, 2017, 06:58 PM |
Mackin James P | President & CEO | Feb 19, 2017 | Option Exercise | $17.25 | 16,691 | 287,920 | 412,338 | Feb 22, 2017, 06:58 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2017 | Option Exercise | $17.25 | 18,614 | 321,092 | 291,396 | Feb 22, 2017, 06:55 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2017 | Option Exercise | $17.25 | 4,434 | 76,487 | 288,292 | Feb 22, 2017, 06:55 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 19, 2017 | Option Exercise | $17.25 | 10,471 | 180,625 | 92,751 | Feb 22, 2017, 06:53 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 19, 2017 | Option Exercise | $17.25 | 2,263 | 39,037 | 91,006 | Feb 22, 2017, 06:53 PM |
Holloway Jean F | VP, General Counsel | Feb 19, 2017 | Option Exercise | $17.25 | 13,262 | 228,770 | 46,829 | Feb 22, 2017, 06:50 PM |
Holloway Jean F | VP, General Counsel | Feb 19, 2017 | Option Exercise | $17.25 | 2,996 | 51,681 | 44,617 | Feb 22, 2017, 06:50 PM |
Gale David C | VP, Research & Development | Feb 19, 2017 | Option Exercise | $17.25 | 10,471 | 180,625 | 78,854 | Feb 22, 2017, 06:39 PM |
Gale David C | VP, Research & Development | Feb 19, 2017 | Option Exercise | $17.25 | 2,522 | 43,505 | 77,109 | Feb 22, 2017, 06:39 PM |
Davis John E | Senior VP, Global Sales | Feb 19, 2017 | Option Exercise | $17.25 | 13,262 | 228,770 | 32,576 | Feb 22, 2017, 06:36 PM |
Davis John E | Senior VP, Global Sales | Feb 19, 2017 | Option Exercise | $17.25 | 2,212 | 38,157 | 30,364 | Feb 22, 2017, 06:36 PM |
Capps Scott B | VP, Clinical Research | Feb 19, 2017 | Option Exercise | $17.25 | 10,471 | 180,625 | 109,113 | Feb 22, 2017, 06:33 PM |
Capps Scott B | VP, Clinical Research | Feb 19, 2017 | Option Exercise | $17.25 | 2,532 | 43,677 | 107,366 | Feb 22, 2017, 06:33 PM |
Benson James | Director | Jan 03, 2017 | Option Exercise | $19.10 | 2,000 | 38,200 | 60,086 | Jan 05, 2017, 04:58 PM |
RONALD C ELKINS | Director | Nov 23, 2016 | Option Exercise | $20.00 | 2,000 | 40,000 | 97,586 | Nov 28, 2016, 04:45 PM |
RONALD C ELKINS | Director | Nov 14, 2016 | Option Exercise | $18.65 | 2,000 | 37,302 | 99,586 | Nov 16, 2016, 04:48 PM |
Benson James | Director | Oct 31, 2016 | Option Exercise | $16.75 | 2,000 | 33,501 | 62,086 | Nov 01, 2016, 04:32 PM |
RONALD C ELKINS | Director | Sep 20, 2016 | Option Exercise | $18.00 | 1,000 | 18,000 | 101,586 | Sep 22, 2016, 05:00 PM |
McCall Ronald D | Director | Sep 15, 2016 | Option Exercise | $17.54 | 3,000 | 52,631 | 153,248 | Sep 16, 2016, 04:31 PM |
Matthews William Robert | Senior VP, Operations, Quality | Sep 13, 2016 | Option Exercise | $17.39 | 1,156 | 20,100 | 18,970 | Sep 15, 2016, 05:00 PM |
Holloway Jean F | VP, General Counsel | Sep 12, 2016 | Option Exercise | $17.03 | 3,000 | 51,081 | 34,351 | Sep 14, 2016, 05:30 PM |
Holloway Jean F | VP, General Counsel | Sep 12, 2016 | Option Exercise | $9.64 | 3,000 | 28,920 | 37,351 | Sep 14, 2016, 05:30 PM |
Gale David C | VP, Research & Development | Sep 12, 2016 | Option Exercise | $17.49 | 3,000 | 52,459 | 71,190 | Sep 14, 2016, 05:21 PM |
Gale David C | VP, Research & Development | Sep 12, 2016 | Option Exercise | $7.01 | 3,000 | 21,030 | 74,190 | Sep 14, 2016, 05:21 PM |
RONALD C ELKINS | Director | Sep 12, 2016 | Option Exercise | $17.25 | 1,000 | 17,249 | 102,586 | Sep 14, 2016, 05:19 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Sep 09, 2016 | Option Exercise | $17.26 | 28,847 | 498,035 | 272,612 | Sep 13, 2016, 06:07 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Sep 12, 2016 | Option Exercise | $17.29 | 2,986 | 51,629 | 272,612 | Sep 13, 2016, 06:07 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Sep 09, 2016 | Option Exercise | $7.01 | 28,847 | 202,217 | 301,459 | Sep 13, 2016, 06:07 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Sep 12, 2016 | Option Exercise | $7.01 | 4,486 | 31,447 | 275,598 | Sep 13, 2016, 06:07 PM |
Horton Amy | VP, Chief Accounting Officer | Sep 09, 2016 | Option Exercise | $17.53 | 2,000 | 35,057 | 86,548 | Sep 13, 2016, 06:06 PM |
Horton Amy | VP, Chief Accounting Officer | Sep 13, 2016 | Option Exercise | $17.47 | 3,000 | 52,410 | 82,798 | Sep 13, 2016, 06:06 PM |
Benson James | Director | Sep 09, 2016 | Option Exercise | $17.18 | 10,000 | 171,800 | 64,086 | Sep 13, 2016, 06:04 PM |
Horton Amy | VP, Chief Accounting Officer | Jul 26, 2016 | Option Exercise | $14.00 | 6,774 | 94,836 | 88,548 | Jul 28, 2016, 04:34 PM |
Horton Amy | VP, Chief Accounting Officer | Jul 26, 2016 | Option Exercise | $7.01 | 10,000 | 70,100 | 95,322 | Jul 28, 2016, 04:34 PM |
RONALD C ELKINS | Director | Jul 26, 2016 | Sale | $14.00 | 2,000 | 28,000 | 103,586 | Jul 28, 2016, 04:31 PM |
McCall Ronald D | Director | Jun 01, 2016 | Sale | $11.56 | 10,000 | 115,600 | 156,248 | Jun 03, 2016, 07:03 AM |
Benson James | Director | May 10, 2016 | Sale | $12.22 | 5,000 | 61,100 | 65,352 | May 12, 2016, 04:31 PM |
RONALD C ELKINS | Director | Apr 15, 2016 | Sale | $12.00 | 1,000 | 12,000 | 96,852 | Apr 19, 2016, 04:29 PM |
RONALD C ELKINS | Director | Mar 07, 2016 | Sale | $11.18 | 2,000 | 22,360 | 97,852 | Mar 09, 2016, 08:10 AM |
Mackin James P | President & CEO | Mar 03, 2016 | Buy | $10.89 | 5,400 | 58,806 | 363,933 | Mar 04, 2016, 05:20 PM |
Mackin James P | President & CEO | Mar 04, 2016 | Buy | $10.94 | 4,600 | 50,324 | 368,533 | Mar 04, 2016, 05:20 PM |
Gale David C | VP, Research & Development | Feb 26, 2016 | Option Exercise | $10.54 | 416 | 4,385 | 71,606 | Mar 01, 2016, 04:41 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 26, 2016 | Option Exercise | $10.54 | 694 | 7,315 | 272,612 | Mar 01, 2016, 04:39 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 26, 2016 | Option Exercise | $10.54 | 277 | 2,920 | 85,322 | Mar 01, 2016, 04:37 PM |
Capps Scott B | VP, Clinical Research | Feb 26, 2016 | Option Exercise | $10.54 | 416 | 4,385 | 99,427 | Mar 01, 2016, 04:34 PM |
Gale David C | VP, Research & Development | Nov 08, 2013 | Option Exercise | $9.90 | 100 | 990 | 36,199 | Mar 01, 2016, 04:33 PM |
Gale David C | VP, Research & Development | Nov 11, 2013 | Sale | $9.97 | 150 | 1,496 | 36,049 | Mar 01, 2016, 04:33 PM |
Saurini Sherry M | VP, Quality | Feb 19, 2016 | Option Exercise | $10.24 | 5,294 | 54,211 | 5,294 | Feb 23, 2016, 05:47 PM |
Matthews William Robert | Senior VP, Operations, Quality | Feb 19, 2016 | Option Exercise | $10.24 | 9,314 | 95,375 | 17,814 | Feb 23, 2016, 05:45 PM |
Mackin James P | President & CEO | Feb 19, 2016 | Option Exercise | $10.24 | 42,484 | 435,036 | 325,316 | Feb 23, 2016, 05:44 PM |
Mackin James P | President & CEO | Feb 19, 2016 | Option Exercise | $10.24 | 6,647 | 68,065 | 358,533 | Feb 23, 2016, 05:44 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2016 | Option Exercise | $10.24 | 13,072 | 133,857 | 256,356 | Feb 23, 2016, 05:43 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 22, 2016 | Option Exercise | $10.48 | 3,662 | 38,378 | 273,306 | Feb 23, 2016, 05:43 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2016 | Option Exercise | $10.24 | 2,658 | 27,218 | 269,644 | Feb 23, 2016, 05:43 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 19, 2016 | Option Exercise | $10.24 | 7,353 | 75,295 | 80,284 | Feb 23, 2016, 05:41 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 19, 2016 | Option Exercise | $10.24 | 1,063 | 10,885 | 85,599 | Feb 23, 2016, 05:41 PM |
Holloway Jean F | VP, General Counsel | Feb 22, 2016 | Option Exercise | $10.48 | 2,930 | 30,706 | 34,351 | Feb 23, 2016, 05:39 PM |
Holloway Jean F | VP, General Counsel | Feb 19, 2016 | Option Exercise | $10.24 | 9,314 | 95,375 | 23,566 | Feb 23, 2016, 05:39 PM |
Holloway Jean F | VP, General Counsel | Feb 19, 2016 | Option Exercise | $10.24 | 1,521 | 15,575 | 31,421 | Feb 23, 2016, 05:39 PM |
Gale David C | VP, Research & Development | Feb 19, 2016 | Option Exercise | $10.24 | 7,353 | 75,295 | 61,605 | Feb 23, 2016, 05:37 PM |
Gale David C | VP, Research & Development | Feb 19, 2016 | Option Exercise | $10.24 | 1,594 | 16,323 | 69,575 | Feb 23, 2016, 05:37 PM |
Davis John E | Senior VP, Global Sales | Feb 19, 2016 | Option Exercise | $10.24 | 9,314 | 95,375 | 19,314 | Feb 23, 2016, 05:36 PM |
Capps Scott B | VP, Clinical Research | Feb 19, 2016 | Option Exercise | $10.24 | 7,353 | 75,295 | 91,873 | Feb 23, 2016, 05:35 PM |
Capps Scott B | VP, Clinical Research | Feb 19, 2016 | Option Exercise | $10.24 | 1,594 | 16,323 | 99,843 | Feb 23, 2016, 05:35 PM |
Capps Scott B | VP, Clinical Research | Feb 19, 2016 | Option Exercise | $4.83 | 15,000 | 72,450 | 106,455 | Feb 23, 2016, 05:35 PM |
Capps Scott B | VP, Clinical Research | Feb 19, 2016 | Sale | $10.30 | 15,000 | 154,500 | 91,873 | Feb 23, 2016, 05:35 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 17, 2016 | Option Exercise | $10.20 | 4,261 | 43,462 | 72,931 | Feb 19, 2016, 04:36 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 17, 2016 | Option Exercise | $4.83 | 9,000 | 43,470 | 77,192 | Feb 19, 2016, 04:36 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 17, 2016 | Option Exercise | $10.20 | 6,012 | 61,322 | 243,284 | Feb 19, 2016, 04:35 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 18, 2016 | Option Exercise | $4.83 | 8,000 | 38,640 | 251,284 | Feb 19, 2016, 04:35 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 17, 2016 | Option Exercise | $4.83 | 12,700 | 61,341 | 247,166 | Feb 19, 2016, 04:35 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 18, 2016 | Sale | $10.13 | 8,000 | 81,040 | 243,284 | Feb 19, 2016, 04:35 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 12, 2016 | Option Exercise | $9.06 | 1,615 | 14,632 | 241,854 | Feb 16, 2016, 04:38 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 15, 2016 | Option Exercise | $9.06 | 5,558 | 50,355 | 236,296 | Feb 16, 2016, 04:38 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 15, 2016 | Option Exercise | $9.06 | 2,223 | 20,140 | 68,192 | Feb 16, 2016, 04:36 PM |
Horton Amy | VP, Chief Accounting Officer | Feb 12, 2016 | Option Exercise | $9.06 | 645 | 5,844 | 70,415 | Feb 16, 2016, 04:36 PM |
Capps Scott B | VP, Clinical Research | Feb 15, 2016 | Option Exercise | $9.06 | 3,290 | 29,807 | 84,520 | Feb 16, 2016, 04:35 PM |
Capps Scott B | VP, Clinical Research | Feb 12, 2016 | Option Exercise | $9.06 | 942 | 8,535 | 87,810 | Feb 16, 2016, 04:35 PM |
Gale David C | VP, Research & Development | Feb 15, 2016 | Option Exercise | $9.06 | 3,283 | 29,744 | 54,252 | Feb 16, 2016, 04:33 PM |
Gale David C | VP, Research & Development | Feb 12, 2016 | Option Exercise | $9.06 | 942 | 8,535 | 57,535 | Feb 16, 2016, 04:33 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Dec 28, 2015 | Option Exercise | $4.83 | 1,000 | 4,830 | 244,669 | Dec 30, 2015, 03:25 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Dec 28, 2015 | Sale | $11.00 | 700 | 7,700 | 243,969 | Dec 30, 2015, 03:25 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 27, 2015 | Option Exercise | $4.83 | 10,581 | 51,106 | 250,550 | Dec 01, 2015, 04:35 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 30, 2015 | Option Exercise | $4.83 | 5,219 | 25,208 | 243,969 | Dec 01, 2015, 04:35 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 27, 2015 | Sale | $11.03 | 10,581 | 116,708 | 239,969 | Dec 01, 2015, 04:35 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 30, 2015 | Sale | $11.02 | 1,219 | 13,439 | 239,969 | Dec 01, 2015, 04:35 PM |
Benson James | Director | Sep 15, 2015 | Sale | $9.65 | 5,839 | 56,346 | 70,352 | Sep 17, 2015, 08:32 AM |
Benson James | Director | Sep 11, 2015 | Sale | $9.65 | 4,161 | 40,154 | 76,191 | Sep 15, 2015, 04:34 PM |
Benson James | Director | Sep 11, 2015 | Sale | $9.65 | 3,359 | 32,414 | 76,993 | Sep 14, 2015, 04:41 PM |
ANDERSON STEVEN G | Former Executive Chairman | Apr 09, 2015 | Option Exercise | $10.18 | 44,404 | 452,033 | 1,271,846 | Apr 15, 2015, 05:01 PM |
ANDERSON STEVEN G | Former Executive Chairman | Apr 09, 2015 | Option Exercise | $10.18 | 57,681 | 587,193 | 1,258,569 | Apr 13, 2015, 05:30 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 07, 2015 | Option Exercise | $10.51 | 1,739 | 18,277 | 239,719 | Mar 10, 2015, 04:54 PM |
Horton Amy | Chief Accounting Officer | Mar 07, 2015 | Option Exercise | $10.51 | 507 | 5,329 | 71,060 | Mar 10, 2015, 04:53 PM |
Gale David C | VP, Research & Development | Mar 07, 2015 | Option Exercise | $10.51 | 1,043 | 10,962 | 58,477 | Mar 10, 2015, 04:47 PM |
FRONK DAVID | VP, Regulatory Affairs | Mar 07, 2015 | Option Exercise | $10.51 | 1,217 | 12,791 | 110,559 | Mar 10, 2015, 04:45 PM |
Capps Scott B | VP, Clinical Research | Mar 07, 2015 | Option Exercise | $10.51 | 869 | 9,133 | 88,752 | Mar 10, 2015, 04:44 PM |
ANDERSON STEVEN G | Executive Chairman | Mar 07, 2015 | Option Exercise | $10.51 | 5,469 | 57,479 | 1,316,250 | Mar 10, 2015, 04:43 PM |
Anderson Bruce G. | VP, US Sales &Global Marketing | Mar 07, 2015 | Option Exercise | $10.51 | 695 | 7,304 | 42,106 | Mar 10, 2015, 04:41 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 26, 2015 | Option Exercise | $10.72 | 1,389 | 14,890 | 241,458 | Feb 27, 2015, 05:00 PM |
Capps Scott B | VP, Clinical Research | Feb 26, 2015 | Option Exercise | $10.72 | 833 | 8,930 | 89,621 | Feb 27, 2015, 04:58 PM |
ANDERSON STEVEN G | Executive Chairman | Feb 26, 2015 | Option Exercise | $10.72 | 4,298 | 46,075 | 1,321,719 | Feb 27, 2015, 04:56 PM |
FRONK DAVID | VP, Regulatory Affairs | Feb 26, 2015 | Option Exercise | $10.72 | 972 | 10,420 | 111,776 | Feb 27, 2015, 04:55 PM |
Horton Amy | Chief Accounting Officer | Feb 26, 2015 | Option Exercise | $10.72 | 540 | 5,789 | 71,567 | Feb 27, 2015, 04:53 PM |
Gale David C | VP, Research & Development | Feb 26, 2015 | Option Exercise | $10.72 | 833 | 8,930 | 59,520 | Feb 27, 2015, 04:51 PM |
Anderson Bruce G. | VP, US Sales &Global Marketing | Feb 26, 2015 | Option Exercise | $10.72 | 833 | 8,930 | 42,801 | Feb 27, 2015, 04:47 PM |
ANDERSON STEVEN G | Executive Chairman | Feb 23, 2015 | Option Exercise | $10.47 | 59,243 | 620,274 | 1,305,183 | Feb 25, 2015, 08:36 AM |
ANDERSON STEVEN G | Executive Chairman | Feb 23, 2015 | Option Exercise | $9.73 | 63,750 | 620,287 | 1,364,426 | Feb 25, 2015, 08:36 AM |
FRONK DAVID | VP, Regulatory Affairs | Feb 16, 2015 | Option Exercise | $11.30 | 12,915 | 145,940 | 106,914 | Feb 25, 2015, 08:33 AM |
FRONK DAVID | VP, Regulatory Affairs | Feb 16, 2015 | Option Exercise | $9.73 | 15,000 | 145,950 | 119,829 | Feb 25, 2015, 08:33 AM |
Mackin James P | President & CEO | Feb 19, 2015 | Option Exercise | $11.00 | 30,832 | 339,152 | 280,832 | Feb 20, 2015, 04:55 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2015 | Option Exercise | $11.00 | 12,333 | 135,663 | 234,513 | Feb 20, 2015, 04:53 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 18, 2015 | Option Exercise | $10.82 | 5,558 | 60,138 | 222,180 | Feb 20, 2015, 04:53 PM |
Lang David P. | VP, Int'l Sales & Marketing | Feb 19, 2015 | Option Exercise | $11.00 | 7,399 | 81,389 | 68,441 | Feb 20, 2015, 04:52 PM |
Horton Amy | Chief Accounting Officer | Feb 19, 2015 | Option Exercise | $11.00 | 4,933 | 54,263 | 68,773 | Feb 20, 2015, 04:50 PM |
Horton Amy | Chief Accounting Officer | Feb 18, 2015 | Option Exercise | $10.82 | 1,852 | 20,039 | 63,840 | Feb 20, 2015, 04:50 PM |
Gale David C | VP, Research & Development | Feb 19, 2015 | Option Exercise | $11.00 | 7,399 | 81,389 | 55,353 | Feb 20, 2015, 04:49 PM |
Gale David C | VP, Research & Development | Feb 18, 2015 | Option Exercise | $10.82 | 3,417 | 36,972 | 47,954 | Feb 20, 2015, 04:49 PM |
FRONK DAVID | VP, Regulatory Affairs | Feb 19, 2015 | Option Exercise | $11.00 | 8,633 | 94,963 | 104,829 | Feb 20, 2015, 04:47 PM |
FRONK DAVID | VP, Regulatory Affairs | Feb 18, 2015 | Option Exercise | $10.82 | 4,022 | 43,518 | 96,196 | Feb 20, 2015, 04:47 PM |
Capps Scott B | VP, Clinical Research | Feb 19, 2015 | Option Exercise | $11.00 | 7,399 | 81,389 | 85,454 | Feb 20, 2015, 04:46 PM |
Capps Scott B | VP, Clinical Research | Feb 18, 2015 | Option Exercise | $10.82 | 2,793 | 30,220 | 78,055 | Feb 20, 2015, 04:46 PM |
ANDERSON STEVEN G | Executive Chairman | Feb 18, 2015 | Option Exercise | $10.82 | 11,395 | 123,294 | 1,330,676 | Feb 20, 2015, 04:45 PM |
ANDERSON STEVEN G | Executive Chairman | Feb 19, 2015 | Sale | $10.93 | 30,000 | 327,945 | 1,300,676 | Feb 20, 2015, 04:45 PM |
Anderson Bruce G. | VP, US Sales &Global Marketing | Feb 19, 2015 | Option Exercise | $11.00 | 7,399 | 81,389 | 38,634 | Feb 20, 2015, 04:43 PM |
Anderson Bruce G. | VP, US Sales &Global Marketing | Feb 18, 2015 | Option Exercise | $10.82 | 2,207 | 23,880 | 31,235 | Feb 20, 2015, 04:43 PM |
Horton Amy | Chief Accounting Officer | Feb 12, 2015 | Option Exercise | $11.40 | 748 | 8,527 | 65,692 | Feb 13, 2015, 05:25 PM |
ANDERSON STEVEN G | Chairman | Feb 12, 2015 | Option Exercise | $11.40 | 4,262 | 48,587 | 1,342,071 | Feb 13, 2015, 05:04 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 12, 2015 | Option Exercise | $11.40 | 1,871 | 21,329 | 227,738 | Feb 13, 2015, 05:02 PM |
Anderson Bruce G. | VP, US Sales &Global Marketing | Feb 12, 2015 | Option Exercise | $11.40 | 1,122 | 12,791 | 33,442 | Feb 13, 2015, 04:58 PM |
FRONK DAVID | VP, Regulatory Affairs | Feb 12, 2015 | Option Exercise | $11.40 | 1,310 | 14,934 | 100,218 | Feb 13, 2015, 04:56 PM |
Gale David C | VP, Research & Development | Feb 12, 2015 | Option Exercise | $11.40 | 1,122 | 12,791 | 51,371 | Feb 13, 2015, 04:53 PM |
Capps Scott B | VP, Clinical Research | Feb 12, 2015 | Option Exercise | $11.40 | 1,122 | 12,791 | 80,848 | Feb 13, 2015, 04:50 PM |
Anderson Bruce G. | VP, US Sales &Global Marketing | Dec 09, 2014 | Option Exercise | $9.10 | 3,900 | 35,499 | 37,564 | Dec 10, 2014, 04:50 PM |
Anderson Bruce G. | VP, US Sales &Global Marketing | Dec 09, 2014 | Sale | $10.29 | 3,900 | 40,142 | 34,564 | Dec 10, 2014, 04:50 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Dec 04, 2014 | Option Exercise | $10.52 | 26,500 | 278,899 | 229,609 | Dec 05, 2014, 04:59 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Dec 04, 2014 | Option Exercise | $9.73 | 27,500 | 267,575 | 256,109 | Dec 05, 2014, 04:59 PM |
Horton Amy | Chief Accounting Officer | Dec 02, 2014 | Option Exercise | $10.69 | 8,191 | 87,562 | 66,440 | Dec 04, 2014, 04:47 PM |
Horton Amy | Chief Accounting Officer | Dec 02, 2014 | Option Exercise | $9.73 | 9,000 | 87,570 | 74,631 | Dec 04, 2014, 04:47 PM |
Anderson Bruce G. | VP, US Sales &Global Marketing | Nov 25, 2014 | Option Exercise | $6.57 | 20,211 | 132,757 | 46,997 | Nov 26, 2014, 04:35 PM |
Anderson Bruce G. | VP, US Sales &Global Marketing | Nov 25, 2014 | Sale | $10.11 | 20,211 | 204,368 | 34,564 | Nov 26, 2014, 04:35 PM |
Gale David C | VP, Research & Development | Nov 08, 2014 | Option Exercise | $10.06 | 150 | 1,509 | 52,493 | Nov 12, 2014, 08:36 AM |
RONALD C ELKINS | Director | Nov 05, 2014 | Sale | $10.08 | 4,000 | 40,320 | 89,500 | Nov 06, 2014, 04:53 PM |
Benson James | Director | Nov 03, 2014 | Sale | $10.22 | 10,000 | 102,200 | 70,000 | Nov 04, 2014, 04:45 PM |
Anderson Bruce G. | VP, US Sales &Global Marketing | Oct 30, 2014 | Option Exercise | $5.12 | 10,333 | 52,905 | 44,897 | Nov 03, 2014, 04:52 PM |
Anderson Bruce G. | VP, US Sales &Global Marketing | Oct 30, 2014 | Sale | $10.09 | 10,333 | 104,247 | 34,564 | Nov 03, 2014, 04:52 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Sep 08, 2014 | Option Exercise | $5.12 | 10,000 | 51,200 | 44,564 | Sep 09, 2014, 04:59 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Sep 08, 2014 | Sale | $10.05 | 10,000 | 100,529 | 34,564 | Sep 09, 2014, 04:59 PM |
ANDERSON STEVEN G | Chairman | Sep 02, 2014 | Sale | $10.08 | 20,000 | 201,502 | 1,346,333 | Sep 03, 2014, 04:54 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Aug 25, 2014 | Option Exercise | $5.12 | 5,000 | 25,600 | 39,564 | Aug 26, 2014, 05:01 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Aug 25, 2014 | Sale | $10.05 | 5,000 | 50,255 | 39,393 | Aug 26, 2014, 05:01 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Aug 18, 2014 | Option Exercise | $4.83 | 10,000 | 48,300 | 44,564 | Aug 19, 2014, 05:08 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Aug 18, 2014 | Sale | $10.52 | 10,000 | 105,182 | 34,564 | Aug 19, 2014, 05:08 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Aug 15, 2014 | Option Exercise | $10.43 | 3,355 | 34,993 | 95,221 | Aug 19, 2014, 05:06 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Aug 15, 2014 | Option Exercise | $7.00 | 5,000 | 35,000 | 98,576 | Aug 19, 2014, 05:06 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 14, 2014 | Option Exercise | $9.73 | 119 | 1,158 | 228,728 | Aug 15, 2014, 05:01 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 13, 2014 | Option Exercise | $9.73 | 9,881 | 96,142 | 238,490 | Aug 15, 2014, 05:01 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 14, 2014 | Sale | $10.50 | 119 | 1,250 | 228,609 | Aug 15, 2014, 05:01 PM |
LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 13, 2014 | Sale | $10.51 | 9,881 | 103,849 | 228,609 | Aug 15, 2014, 05:01 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Aug 13, 2014 | Option Exercise | $5.12 | 11,000 | 56,320 | 104,576 | Aug 14, 2014, 05:22 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Aug 13, 2014 | Sale | $10.50 | 11,000 | 115,500 | 93,576 | Aug 14, 2014, 05:22 PM |
RONALD C ELKINS | Director | Jul 29, 2014 | Sale | $9.67 | 2,500 | 24,175 | 83,500 | Jul 31, 2014, 05:10 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Jul 28, 2014 | Sale | $9.52 | 19,477 | 185,501 | 1,366,333 | Jul 29, 2014, 05:00 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Jul 28, 2014 | Option Exercise | $4.83 | 5,000 | 24,150 | 39,564 | Jul 29, 2014, 04:56 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Jul 28, 2014 | Sale | $9.48 | 5,000 | 47,424 | 35,564 | Jul 29, 2014, 04:56 PM |
Horton Amy | Chief Accounting Officer | Jun 09, 2014 | Sale | $9.26 | 2,500 | 23,152 | 65,631 | Jun 11, 2014, 05:06 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | May 16, 2014 | Sale | $8.61 | 8,952 | 77,088 | 101,528 | May 19, 2014, 05:02 PM |
ANDERSON STEVEN G | President, CEO and Chairman | May 12, 2014 | Sale | $9.00 | 29,223 | 263,051 | 1,387,110 | May 14, 2014, 05:00 PM |
ANDERSON STEVEN G | President, CEO and Chairman | May 13, 2014 | Sale | $9.00 | 1,300 | 11,704 | 1,385,810 | May 14, 2014, 05:00 PM |
Anderson Bruce G. | VP, US Sales and Marketing | May 06, 2014 | Sale | $8.81 | 14,047 | 123,754 | 34,564 | May 06, 2014, 05:18 PM |
Anderson Bruce G. | VP, US Sales and Marketing | May 02, 2014 | Sale | $8.94 | 2,823 | 25,244 | 51,382 | May 06, 2014, 05:18 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Mar 07, 2014 | Option Exercise | $9.87 | 1,739 | 17,164 | 228,609 | Mar 10, 2014, 05:27 PM |
Horton Amy | Chief Accounting Officer | Mar 07, 2014 | Option Exercise | $9.87 | 521 | 5,142 | 68,131 | Mar 10, 2014, 05:26 PM |
Gale David C | VP-Research and Development | Mar 07, 2014 | Option Exercise | $9.87 | 1,025 | 10,117 | 52,643 | Mar 10, 2014, 05:26 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Mar 07, 2014 | Option Exercise | $9.87 | 1,217 | 12,012 | 110,480 | Mar 10, 2014, 05:26 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Mar 07, 2014 | Option Exercise | $9.87 | 1,217 | 12,012 | 93,576 | Mar 10, 2014, 05:25 PM |
Capps Scott B | VP-Clinical Research | Mar 07, 2014 | Option Exercise | $9.87 | 869 | 8,577 | 81,970 | Mar 10, 2014, 05:25 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Mar 07, 2014 | Option Exercise | $9.87 | 6,252 | 61,707 | 1,416,333 | Mar 10, 2014, 05:25 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Mar 07, 2014 | Option Exercise | $9.87 | 695 | 6,860 | 51,434 | Mar 10, 2014, 05:25 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Feb 24, 2014 | Option Exercise | $9.79 | 10,560 | 103,382 | 213,681 | Feb 26, 2014, 06:07 PM |
Horton Amy | Chief Accounting Officer | Feb 24, 2014 | Option Exercise | $9.79 | 3,046 | 29,820 | 61,985 | Feb 26, 2014, 06:00 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 24, 2014 | Option Exercise | $9.79 | 7,322 | 71,682 | 100,030 | Feb 26, 2014, 05:57 PM |
Capps Scott B | VP-Clinical Research | Feb 24, 2014 | Option Exercise | $9.79 | 5,200 | 50,908 | 72,839 | Feb 26, 2014, 05:56 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Feb 24, 2014 | Option Exercise | $9.79 | 7,330 | 71,761 | 83,126 | Feb 26, 2014, 05:54 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Feb 24, 2014 | Option Exercise | $9.79 | 26,342 | 257,888 | 1,380,918 | Feb 26, 2014, 05:52 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Feb 24, 2014 | Option Exercise | $9.79 | 4,197 | 41,089 | 42,129 | Feb 26, 2014, 05:51 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Feb 21, 2014 | Option Exercise | $9.79 | 3,229 | 31,612 | 224,241 | Feb 25, 2014, 06:05 PM |
Horton Amy | Chief Accounting Officer | Feb 21, 2014 | Option Exercise | $9.79 | 1,257 | 12,306 | 65,031 | Feb 25, 2014, 06:00 PM |
Gale David C | VP-Research and Development | Feb 21, 2014 | Option Exercise | $9.79 | 1,972 | 19,306 | 43,668 | Feb 25, 2014, 05:57 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 21, 2014 | Option Exercise | $9.79 | 2,199 | 21,528 | 107,352 | Feb 25, 2014, 05:50 PM |
Capps Scott B | VP-Clinical Research | Feb 21, 2014 | Option Exercise | $9.79 | 1,888 | 18,484 | 78,039 | Feb 25, 2014, 05:48 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Feb 21, 2014 | Option Exercise | $9.79 | 2,199 | 21,528 | 90,456 | Feb 25, 2014, 05:45 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Feb 21, 2014 | Option Exercise | $9.79 | 1,903 | 18,630 | 46,326 | Feb 25, 2014, 05:42 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Feb 21, 2014 | Option Exercise | $9.79 | 8,075 | 79,054 | 1,407,260 | Feb 25, 2014, 05:37 PM |
Horton Amy | Chief Accounting Officer | Feb 18, 2014 | Option Exercise | $10.71 | 1,827 | 19,567 | 58,540 | Feb 20, 2014, 05:25 PM |
Horton Amy | Chief Accounting Officer | Feb 18, 2014 | Option Exercise | $8.70 | 2,250 | 19,575 | 60,367 | Feb 20, 2014, 05:25 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Dec 30, 2013 | Option Exercise | $10.94 | 50,696 | 554,614 | 1,366,906 | Dec 31, 2013, 12:04 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Dec 30, 2013 | Option Exercise | $8.70 | 63,750 | 554,625 | 1,417,602 | Dec 31, 2013, 12:04 PM |
Capps Scott B | VP-Clinical Research | Nov 27, 2013 | Option Exercise | $9.06 | 25,000 | 226,500 | 93,303 | Dec 02, 2013, 05:43 PM |
Capps Scott B | VP-Clinical Research | Nov 27, 2013 | Sale | $10.60 | 25,000 | 265,103 | 68,303 | Dec 02, 2013, 05:43 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Nov 26, 2013 | Option Exercise | $7.00 | 5,000 | 35,000 | 84,099 | Nov 26, 2013, 05:03 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Nov 26, 2013 | Sale | $10.50 | 5,000 | 52,500 | 79,099 | Nov 26, 2013, 05:03 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Nov 11, 2013 | Option Exercise | $8.70 | 10,132 | 88,148 | 105,437 | Nov 13, 2013, 05:40 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Nov 12, 2013 | Sale | $9.92 | 9,442 | 93,630 | 95,995 | Nov 13, 2013, 05:40 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Nov 08, 2013 | Option Exercise | $9.90 | 4,277 | 42,342 | 95,305 | Nov 12, 2013, 05:19 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Nov 08, 2013 | Option Exercise | $8.70 | 4,868 | 42,352 | 99,582 | Nov 12, 2013, 05:19 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Nov 11, 2013 | Option Exercise | $7.00 | 5,000 | 35,000 | 84,099 | Nov 12, 2013, 05:15 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Nov 11, 2013 | Sale | $10.00 | 5,000 | 50,000 | 79,099 | Nov 12, 2013, 05:15 PM |
Gale David C | VP-Research and Development | Nov 08, 2013 | Option Exercise | $9.90 | 100 | 990 | 34,169 | Nov 12, 2013, 05:14 PM |
Gale David C | VP-Research and Development | Nov 11, 2013 | Sale | $9.97 | 150 | 1,496 | 34,019 | Nov 12, 2013, 05:14 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Nov 07, 2013 | Sale | $9.47 | 23,375 | 221,448 | 1,358,120 | Nov 07, 2013, 05:13 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Nov 06, 2013 | Sale | $9.30 | 31,121 | 289,516 | 1,381,495 | Nov 07, 2013, 05:13 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Nov 05, 2013 | Sale | $9.39 | 45,504 | 427,228 | 1,412,616 | Nov 07, 2013, 05:13 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Nov 04, 2013 | Option Exercise | $8.70 | 12,500 | 108,750 | 220,012 | Nov 06, 2013, 05:16 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Nov 04, 2013 | Sale | $9.65 | 11,909 | 114,961 | 208,103 | Nov 06, 2013, 05:16 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Nov 04, 2013 | Option Exercise | $7.00 | 5,000 | 35,000 | 84,099 | Nov 06, 2013, 05:11 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Nov 04, 2013 | Sale | $9.53 | 5,000 | 47,650 | 79,099 | Nov 06, 2013, 05:11 PM |
Horton Amy | Chief Accounting Officer | Nov 01, 2013 | Option Exercise | $9.46 | 6,207 | 58,718 | 58,117 | Nov 05, 2013, 05:15 PM |
Horton Amy | Chief Accounting Officer | Nov 01, 2013 | Option Exercise | $8.70 | 6,750 | 58,725 | 64,324 | Nov 05, 2013, 05:15 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Oct 29, 2013 | Option Exercise | $9.00 | 24,166 | 217,494 | 207,512 | Oct 31, 2013, 05:06 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Oct 29, 2013 | Option Exercise | $8.70 | 25,000 | 217,500 | 231,678 | Oct 31, 2013, 05:06 PM |
RONALD C ELKINS | Director | Oct 29, 2013 | Sale | $9.00 | 2,000 | 18,000 | 86,000 | Oct 31, 2013, 05:05 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Oct 29, 2013 | Option Exercise | $7.00 | 5,000 | 35,000 | 84,099 | Oct 31, 2013, 05:05 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Oct 29, 2013 | Sale | $9.00 | 5,000 | 45,000 | 79,099 | Oct 31, 2013, 05:05 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Aug 27, 2013 | Sale | $6.33 | 4,500 | 28,464 | 36,608 | Aug 28, 2013, 05:17 PM |
RONALD C ELKINS | Director | Aug 05, 2013 | Sale | $7.02 | 2,000 | 14,041 | 88,000 | Aug 14, 2013, 05:54 PM |
Horton Amy | Chief Accounting Officer | Aug 08, 2013 | Sale | $7.07 | 2,500 | 17,675 | 57,574 | Aug 09, 2013, 05:03 PM |
McCall Ronald D | Director | Aug 01, 2013 | Sale | $7.10 | 6,000 | 42,588 | 137,162 | Aug 02, 2013, 04:49 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Jul 12, 2013 | Option Exercise | $7.28 | 4,975 | 36,218 | 79,099 | Jul 16, 2013, 05:21 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Jul 12, 2013 | Option Exercise | $4.83 | 7,500 | 36,225 | 84,074 | Jul 16, 2013, 05:21 PM |
McCall Ronald D | Director | Jun 06, 2013 | Sale | $6.11 | 2,000 | 12,221 | 143,173 | Jun 07, 2013, 05:07 PM |
McCall Ronald D | Director | Jun 05, 2013 | Sale | $6.19 | 2,000 | 12,380 | 145,162 | Jun 07, 2013, 05:07 PM |
RONALD C ELKINS | Director | May 31, 2013 | Sale | $6.15 | 2,250 | 13,831 | 90,000 | Jun 03, 2013, 05:04 PM |
Lang David P. | Sr. VP, Intl Sales & Marketing | Mar 07, 2013 | Option Exercise | $6.08 | 1,353 | 8,226 | 39,421 | Mar 11, 2013, 06:01 PM |
Gale David C | VP-Research and Development | Mar 07, 2013 | Option Exercise | $6.08 | 2,030 | 12,342 | 34,269 | Mar 11, 2013, 05:51 PM |
Horton Amy | Chief Accounting Officer | Mar 07, 2013 | Option Exercise | $6.08 | 827 | 5,028 | 60,074 | Mar 11, 2013, 05:48 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Mar 07, 2013 | Option Exercise | $6.08 | 8,697 | 52,878 | 1,458,120 | Mar 11, 2013, 05:42 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Mar 07, 2013 | Option Exercise | $6.08 | 3,018 | 18,349 | 94,714 | Mar 11, 2013, 05:40 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Mar 07, 2013 | Option Exercise | $6.08 | 1,353 | 8,226 | 41,108 | Mar 11, 2013, 05:37 PM |
Capps Scott B | VP-Clinical Research | Mar 07, 2013 | Option Exercise | $6.08 | 1,530 | 9,302 | 68,303 | Mar 11, 2013, 05:34 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Mar 07, 2013 | Option Exercise | $6.08 | 4,208 | 25,585 | 206,678 | Mar 11, 2013, 05:30 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Mar 07, 2013 | Option Exercise | $6.08 | 2,799 | 17,018 | 76,297 | Mar 11, 2013, 05:26 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Feb 22, 2013 | Option Exercise | $6.12 | 5,891 | 36,053 | 210,886 | Feb 26, 2013, 05:41 PM |
Horton Amy | Chief Accounting Officer | Feb 22, 2013 | Option Exercise | $6.12 | 1,322 | 8,091 | 60,901 | Feb 26, 2013, 05:37 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 22, 2013 | Option Exercise | $6.12 | 4,736 | 28,984 | 97,732 | Feb 26, 2013, 05:35 PM |
Capps Scott B | VP-Clinical Research | Feb 22, 2013 | Option Exercise | $6.12 | 2,370 | 14,504 | 69,833 | Feb 26, 2013, 05:32 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Feb 22, 2013 | Option Exercise | $6.12 | 4,402 | 26,940 | 79,096 | Feb 26, 2013, 05:29 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Feb 22, 2013 | Option Exercise | $6.12 | 13,895 | 85,037 | 1,466,817 | Feb 26, 2013, 05:26 PM |
Anderson Bruce G. | VP, US Sales and Marketing | Feb 22, 2013 | Option Exercise | $6.12 | 2,163 | 13,238 | 42,461 | Feb 26, 2013, 05:23 PM |
SEERY GERALD B | Sr. VP, Sales and Marketing | Nov 30, 2012 | Sale | $5.94 | 4,360 | 25,906 | 71,999 | Dec 03, 2012, 04:22 PM |
McCall Ronald D | Director | Nov 14, 2012 | Sale | $5.72 | 6,000 | 34,322 | 137,162 | Nov 15, 2012, 05:44 PM |
Gale David C | VP-Research and Development | Nov 08, 2012 | Option Exercise | $5.79 | 243 | 1,407 | 13,782 | Nov 13, 2012, 04:22 PM |
RONALD C ELKINS | Director | Aug 27, 2012 | Sale | $5.34 | 3,000 | 16,031 | 82,250 | Aug 28, 2012, 05:20 PM |
Salveson Jon W | Director | Jun 07, 2012 | Buy | $4.79 | 25,000 | 119,837 | 35,000 | Jun 11, 2012, 07:45 AM |
RONALD C ELKINS | Director | Jun 01, 2012 | Sale | $4.57 | 3,000 | 13,704 | 85,250 | Jun 05, 2012, 04:49 PM |
McCall Ronald D | Director | May 30, 2012 | Sale | $4.52 | 6,000 | 27,115 | 143,162 | May 31, 2012, 04:26 PM |
McCall Ronald D | Director | May 29, 2012 | Sale | $4.57 | 4,000 | 18,276 | 149,162 | May 31, 2012, 04:26 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | May 21, 2012 | Buy | $4.90 | 1,000 | 4,900 | 5,000 | May 23, 2012, 09:32 AM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | May 21, 2012 | Buy | $4.90 | 1,100 | 5,385 | 179,247 | May 23, 2012, 09:32 AM |
RONALD C ELKINS | Director | Feb 21, 2012 | Sale | $5.61 | 5,000 | 28,025 | 78,250 | Feb 22, 2012, 05:14 PM |
Capps Scott B | VP-Clinical Research | Feb 16, 2012 | Option Exercise | $5.98 | 1,622 | 9,700 | 43,440 | Feb 21, 2012, 04:54 PM |
Horton Amy | Chief Accounting Officer | Feb 16, 2012 | Option Exercise | $5.98 | 793 | 4,742 | 44,298 | Feb 21, 2012, 11:12 AM |
SEERY GERALD B | Sr. VP, Sales and Marketing | Feb 16, 2012 | Option Exercise | $5.98 | 2,433 | 14,549 | 64,692 | Feb 21, 2012, 11:09 AM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Feb 16, 2012 | Option Exercise | $5.98 | 3,306 | 19,770 | 161,480 | Feb 21, 2012, 11:07 AM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 16, 2012 | Option Exercise | $5.98 | 1,972 | 11,793 | 64,530 | Feb 21, 2012, 11:03 AM |
Burris Jeffrey W | Vice President & Gen. Counsel | Feb 16, 2012 | Option Exercise | $5.98 | 1,872 | 11,195 | 44,879 | Feb 21, 2012, 10:57 AM |
ANDERSON STEVEN G | President, CEO and Chairman | Feb 16, 2012 | Option Exercise | $5.98 | 6,895 | 41,232 | 1,353,034 | Feb 21, 2012, 10:46 AM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 07, 2012 | Option Exercise | $5.86 | 18,673 | 109,424 | 66,502 | Feb 08, 2012, 05:14 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 07, 2012 | Option Exercise | $5.80 | 18,883 | 109,427 | 85,175 | Feb 08, 2012, 05:14 PM |
SEERY GERALD B | Sr. VP, Sales and Marketing | Feb 03, 2012 | Option Exercise | $5.85 | 21,099 | 123,429 | 67,125 | Feb 07, 2012, 03:46 PM |
SEERY GERALD B | Sr. VP, Sales and Marketing | Feb 03, 2012 | Option Exercise | $5.80 | 21,300 | 123,434 | 88,224 | Feb 07, 2012, 03:46 PM |
HEACOX ALBERT E | Sr. VP Research and Devl | Dec 31, 2011 | Option Exercise | $4.80 | 2,433 | 11,678 | 110,144 | Jan 04, 2012, 04:10 PM |
RONALD C ELKINS | Director | Dec 06, 2011 | Sale | $4.56 | 3,000 | 13,681 | 84,950 | Dec 07, 2011, 04:09 PM |
McCall Ronald D | Director | Nov 22, 2011 | Sale | $4.35 | 10,000 | 43,500 | 143,162 | Nov 23, 2011, 11:25 AM |
ANDERSON STEVEN G | President, CEO and Chairman | Nov 18, 2011 | Sale | $4.49 | 5,000 | 22,464 | 1,369,929 | Nov 21, 2011, 04:22 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Nov 21, 2011 | Buy | $4.34 | 4,000 | 17,355 | 4,000 | Nov 21, 2011, 04:19 PM |
SEERY GERALD B | Sr. VP, Sales and Marketing | Aug 19, 2011 | Option Exercise | $4.97 | 12,358 | 61,419 | 66,924 | Aug 23, 2011, 01:26 PM |
SEERY GERALD B | Sr. VP, Sales and Marketing | Aug 19, 2011 | Option Exercise | $4.25 | 21,099 | 89,671 | 79,282 | Aug 23, 2011, 01:26 PM |
HEACOX ALBERT E | Sr. VP Research and Devl | Aug 15, 2011 | Option Exercise | $5.33 | 12,319 | 65,660 | 112,577 | Aug 17, 2011, 10:32 AM |
HEACOX ALBERT E | Sr. VP Research and Devl | Aug 15, 2011 | Option Exercise | $4.25 | 15,450 | 65,663 | 124,896 | Aug 17, 2011, 10:32 AM |
ANDERSON STEVEN G | President, CEO and Chairman | Aug 09, 2011 | Option Exercise | $5.44 | 49,609 | 269,873 | 1,374,929 | Aug 11, 2011, 02:06 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Aug 09, 2011 | Option Exercise | $4.25 | 63,500 | 269,875 | 1,424,538 | Aug 11, 2011, 02:06 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Jul 26, 2011 | Option Exercise | $5.67 | 10,313 | 58,475 | 66,292 | Jul 28, 2011, 02:02 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Jul 26, 2011 | Option Exercise | $4.25 | 13,760 | 58,480 | 76,605 | Jul 28, 2011, 02:02 PM |
SEERY GERALD B | Sr. VP, Sales and Marketing | Jul 14, 2011 | Option Exercise | $4.25 | 101 | 429 | 58,284 | Jul 15, 2011, 05:06 PM |
SEERY GERALD B | Sr. VP, Sales and Marketing | Jul 13, 2011 | Option Exercise | $4.25 | 300 | 1,275 | 58,483 | Jul 15, 2011, 05:06 PM |
SEERY GERALD B | Sr. VP, Sales and Marketing | Jul 13, 2011 | Sale | $6.00 | 300 | 1,800 | 58,183 | Jul 15, 2011, 05:06 PM |
SEERY GERALD B | Sr. VP, Sales and Marketing | Jul 14, 2011 | Sale | $6.00 | 101 | 606 | 58,183 | Jul 15, 2011, 05:06 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Jul 07, 2011 | Option Exercise | $5.91 | 13,790 | 81,499 | 164,786 | Jul 11, 2011, 09:11 AM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Jul 07, 2011 | Option Exercise | $4.25 | 17,200 | 73,100 | 178,576 | Jul 11, 2011, 09:11 AM |
Horton Amy | Chief Accounting Officer | Jul 07, 2011 | Option Exercise | $5.91 | 6,472 | 38,250 | 45,091 | Jul 11, 2011, 09:09 AM |
Horton Amy | Chief Accounting Officer | Jul 07, 2011 | Option Exercise | $4.25 | 9,000 | 38,250 | 51,563 | Jul 11, 2011, 09:09 AM |
RONALD C ELKINS | Director | May 05, 2011 | Sale | $5.40 | 4,000 | 21,613 | 77,512 | May 09, 2011, 04:26 PM |
Benson James | Director | May 04, 2011 | Option Exercise | $5.00 | 10,000 | 50,000 | 50,000 | May 06, 2011, 04:34 PM |
Benson James | Director | May 04, 2011 | Sale | $5.43 | 10,000 | 54,289 | 40,000 | May 06, 2011, 04:34 PM |
BEVEVINO DANIEL J | Director | May 05, 2011 | Option Exercise | $5.00 | 10,000 | 50,000 | 45,000 | May 06, 2011, 04:25 PM |
BEVEVINO DANIEL J | Director | May 05, 2011 | Sale | $5.37 | 10,000 | 53,696 | 35,000 | May 06, 2011, 04:25 PM |
ACKERMAN THOMAS F | Director | May 03, 2011 | Option Exercise | $5.00 | 10,000 | 50,000 | 45,000 | May 05, 2011, 04:28 PM |
ACKERMAN THOMAS F | Director | May 03, 2011 | Sale | $5.53 | 10,000 | 55,296 | 35,000 | May 05, 2011, 04:28 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Apr 26, 2011 | Option Exercise | $5.66 | 8,886 | 50,295 | 1,361,038 | Apr 28, 2011, 02:31 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Apr 26, 2011 | Option Exercise | $5.03 | 10,000 | 50,300 | 1,369,924 | Apr 28, 2011, 02:31 PM |
McCall Ronald D | Director | Apr 13, 2011 | Option Exercise | $5.00 | 3,200 | 16,000 | 140,412 | Apr 14, 2011, 02:35 PM |
ANDERSON STEVEN G | President, CEO and Chairman | Feb 19, 2011 | Option Exercise | $5.37 | 2,810 | 15,090 | 1,281,257 | Feb 22, 2011, 05:09 PM |
Horton Amy | Chief Accounting Officer | Feb 19, 2011 | Option Exercise | $5.37 | 396 | 2,127 | 33,230 | Feb 22, 2011, 05:06 PM |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 19, 2011 | Option Exercise | $5.37 | 1,011 | 5,429 | 40,845 | Feb 22, 2011, 05:02 PM |
SEERY GERALD B | Sr. VP, Sales and Marketing | Feb 19, 2011 | Option Exercise | $5.37 | 1,103 | 5,923 | 36,183 | Feb 22, 2011, 04:59 PM |
HEACOX ALBERT E | Sr. VP Research and Devl | Feb 19, 2011 | Option Exercise | $5.37 | 1,178 | 6,326 | 87,446 | Feb 22, 2011, 04:53 PM |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | Feb 19, 2011 | Option Exercise | $5.37 | 1,652 | 8,871 | 129,709 | Feb 22, 2011, 04:48 PM |
Burris Jeffrey W | Vice President & Gen. Counsel | Feb 04, 2011 | Option Exercise | $5.31 | 3,245 | 17,231 | 24,751 | Feb 08, 2011, 12:07 PM |
McCall Ronald D | Director | Nov 15, 2010 | Sale | $5.81 | 3,000 | 17,430 | 137,212 | Nov 16, 2010, 04:58 PM |
McCall Ronald D | Director | Nov 12, 2010 | Sale | $5.89 | 7,000 | 41,238 | 140,212 | Nov 16, 2010, 04:58 PM |
RONALD C ELKINS | Director | Nov 12, 2010 | Sale | $6.00 | 2,000 | 12,008 | 81,442 | Nov 15, 2010, 04:38 PM |
Capps Scott B | VP-Clinical Research | Jul 30, 2010 | Option Exercise | $5.36 | 1,622 | 8,694 | 29,395 | Aug 02, 2010, 04:50 PM |
Owner | Relationship | Date | Value($) |
Stanton Marshall S. | SVP, Clinical & MD Affair | 03/20/2024 | 44,511 |
GREEN ANDREW M | VP Regulatory | 03/15/2024 | 29,240 |
GREEN ANDREW M | VP Regulatory | 03/14/2024 | 79,880 |
Getz Matthew A | VP, Human Resources | 03/12/2024 | 99,719 |
Horton Amy | VP, Chief Accounting Officer | 02/26/2024 | 43,259 |
Stanton Marshall S. | SVP, Clinical & MD Affair | 02/26/2024 | 60,955 |
Maney Rochelle L. | VP, Quality | 02/26/2024 | 46,259 |
Holloway Jean F | SVP, General Counsel | 02/26/2024 | 57,529 |
GREEN ANDREW M | VP Regulatory | 02/26/2024 | 47,982 |
Davis John E | Chief Commercial Officer | 02/26/2024 | 70,158 |
Stanton Marshall S. | SVP, Clinical & MD Affair | 02/27/2024 | 9,223 |
Maney Rochelle L. | VP, Quality | 02/27/2024 | 7,339 |
GREEN ANDREW M | VP Regulatory | 02/27/2024 | 8,350 |
Horton Amy | VP, Chief Accounting Officer | 02/27/2024 | 6,446 |
Davis John E | Chief Commercial Officer | 02/27/2024 | 11,583 |
Mackin James P | President & CEO | 02/26/2024 | 625,080 |
Holloway Jean F | SVP, General Counsel | 02/27/2024 | 9,620 |
Horton Amy | VP, Chief Accounting Officer | 03/05/2024 | 21,568 |
Stanton Marshall S. | SVP, Clinical & MD Affair | 03/01/2024 | 28,195 |
Getz Matthew A | VP, Human Resources | 02/26/2024 | 46,218 |
Getz Matthew A | VP, Human Resources | 02/27/2024 | 6,446 |
Maney Rochelle L. | VP, Quality | 03/05/2024 | 21,662 |
Mackin James P | President & CEO | 02/27/2024 | 95,939 |
Holloway Jean F | SVP, General Counsel | 03/05/2024 | 44,559 |
GREEN ANDREW M | VP Regulatory | 03/05/2024 | 21,718 |
Getz Matthew A | VP, Human Resources | 03/05/2024 | 21,661 |
Davis John E | Chief Commercial Officer | 03/05/2024 | 37,856 |
Mackin James P | President & CEO | 03/05/2024 | 262,037 |
Mackin James P | President & CEO | 03/05/2024 | 262,037 |
Holloway Jean F | SVP, General Counsel | 03/05/2024 | 44,559 |
Davis John E | Chief Commercial Officer | 03/05/2024 | 37,856 |
Getz Matthew A | VP, Human Resources | 03/05/2024 | 21,661 |
Maney Rochelle L. | VP, Quality | 03/05/2024 | 21,662 |
GREEN ANDREW M | VP Regulatory | 03/05/2024 | 21,718 |
Stanton Marshall S. | SVP, Clinical & MD Affair | 03/05/2024 | 28,195 |
Horton Amy | VP, Chief Accounting Officer | 03/05/2024 | 21,568 |
Tyrs Florian | VP, Global Operations | 02/27/2024 | 6,724 |
Horton Amy | VP, Chief Accounting Officer | 02/27/2024 | 6,446 |
Mackin James P | President & CEO | 02/27/2024 | 95,939 |
Holloway Jean F | SVP, General Counsel | 02/27/2024 | 9,620 |
Davis John E | Chief Commercial Officer | 02/27/2024 | 11,583 |
Maney Rochelle L. | VP, Quality | 02/27/2024 | 7,339 |
Getz Matthew A | VP, Human Resources | 02/27/2024 | 6,446 |
GREEN ANDREW M | VP Regulatory | 02/27/2024 | 8,350 |
Stanton Marshall S. | SVP, Clinical & MD Affair | 02/27/2024 | 9,223 |
Horton Amy | VP, Chief Accounting Officer | 02/26/2024 | 43,907 |
Mackin James P | President & CEO | 02/26/2024 | 634,729 |
Holloway Jean F | SVP, General Counsel | 02/26/2024 | 58,381 |
Maney Rochelle L. | VP, Quality | 02/26/2024 | 46,928 |
Davis John E | Chief Commercial Officer | 02/26/2024 | 71,233 |
Getz Matthew A | VP, Human Resources | 02/26/2024 | 46,887 |
GREEN ANDREW M | VP Regulatory | 02/26/2024 | 48,711 |
Stanton Marshall S. | SVP, Clinical & MD Affair | 02/26/2024 | 61,786 |
Tyrs Florian | VP, Global Operations | 02/26/2024 | 18,103 |
Holloway Jean F | SVP, General Counsel | 02/20/2024 | 66,537 |
Horton Amy | VP, Chief Accounting Officer | 02/20/2024 | 31,976 |
Davis John E | Chief Commercial Officer | 02/20/2024 | 48,219 |
Maney Rochelle L. | VP, Quality | 02/20/2024 | 7,678 |
Getz Matthew A | VP, Human Resources | 02/20/2024 | 31,976 |
Tyrs Florian | VP, Global Operations | 02/20/2024 | 4,697 |
Mackin James P | President & CEO | 02/20/2024 | 965,367 |
Mackin James P | President & CEO | 02/20/2024 | 1,358,818 |
Holloway Jean F | SVP, General Counsel | 01/02/2024 | 346,033 |
Holloway Jean F | SVP, General Counsel | 01/02/2024 | 382,122 |
Davis John E | Senior VP, Global Sales | 01/02/2024 | 221,061 |
Davis John E | Senior VP, Global Sales | 01/02/2024 | 244,116 |
Horton Amy | VP, Chief Accounting Officer | 12/15/2023 | 234,671 |
Horton Amy | VP, Chief Accounting Officer | 12/15/2023 | 273,543 |
Berry Lance A | Executive VP, CFO | 12/06/2023 | 750,001 |
Horton Amy | VP, Chief Accounting Officer | 12/06/2023 | 360,006 |
Horton Amy | VP, Chief Accounting Officer | 11/27/2023 | 30,643 |
Horton Amy | VP, Chief Accounting Officer | 11/27/2023 | 36,431 |
Tyrs Florian | VP, Global Operations | 08/08/2023 | 35,377 |
THOMSON ROBERT C | VP Research & Development | 06/09/2023 | 79,402 |
Maier Dennis B | SVP, Operations | 06/06/2023 | 248,163 |
Getz Matthew A | VP, Human Resources | 06/07/2023 | 100,483 |
Maier Dennis B | SVP, Operations | 03/02/2023 | 15,035 |
Maney Rochelle L. | VP, Quality | 03/02/2023 | 11,011 |
Horton Amy | VP, Chief Accounting Officer | 03/02/2023 | 9,415 |
Getz Matthew A | VP, Human Resources | 03/02/2023 | 9,415 |
Mackin James P | President & CEO | 03/02/2023 | 133,984 |
GREEN ANDREW M | VP Regulatory | 03/02/2023 | 11,065 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/02/2023 | 18,790 |
Stanton Marshall S. | SVP, Clinical & MD Affair | 03/02/2023 | 12,165 |
Davis John E | Senior VP, Global Sales | 03/02/2023 | 15,035 |
Holloway Jean F | SVP, General Counsel | 03/02/2023 | 12,165 |
Horton Amy | VP, Chief Accounting Officer | 02/27/2023 | 18,359 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/27/2023 | 40,030 |
Holloway Jean F | SVP, General Counsel | 02/27/2023 | 25,358 |
Davis John E | Senior VP, Global Sales | 02/27/2023 | 30,961 |
Maney Rochelle L. | VP, Quality | 02/27/2023 | 10,221 |
Maney Rochelle L. | VP, Quality | 02/28/2023 | 5,374 |
Maney Rochelle L. | VP, Quality | 02/27/2023 | 11,360 |
GREEN ANDREW M | VP Regulatory | 02/27/2023 | 22,603 |
Mackin James P | President & CEO | 02/27/2023 | 292,787 |
Maier Dennis B | SVP, Operations | 02/27/2023 | 30,146 |
Stanton Marshall S. | SVP, Clinical & MD Affair | 02/27/2023 | 30,236 |
Getz Matthew A | VP, Human Resources | 02/27/2023 | 20,701 |
Getz Matthew A | VP, Human Resources | 02/19/2023 | 19,642 |
Getz Matthew A | VP, Human Resources | 02/17/2023 | 5,067 |
Holloway Jean F | SVP, General Counsel | 02/17/2023 | 27,711 |
Holloway Jean F | SVP, General Counsel | 02/19/2023 | 23,732 |
Maney Rochelle L. | VP, Quality | 02/17/2023 | 5,626 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2023 | 36,715 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/17/2023 | 8,865 |
Maier Dennis B | SVP, Operations | 02/17/2023 | 5,305 |
Maier Dennis B | SVP, Operations | 02/19/2023 | 19,642 |
Horton Amy | VP, Chief Accounting Officer | 02/19/2023 | 19,055 |
Horton Amy | VP, Chief Accounting Officer | 02/17/2023 | 5,067 |
Horton Amy | VP, Chief Accounting Officer | 02/17/2023 | 212,101 |
Horton Amy | VP, Chief Accounting Officer | 02/17/2023 | 253,553 |
Mackin James P | President & CEO | 02/19/2023 | 149,260 |
Mackin James P | President & CEO | 02/17/2023 | 38,250 |
Davis John E | Senior VP, Global Sales | 02/19/2023 | 31,368 |
Davis John E | Senior VP, Global Sales | 02/17/2023 | 8,181 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/14/2023 | 377,057 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/14/2023 | 421,874 |
Mackin James P | President & CEO | 02/14/2023 | 671,222 |
Mackin James P | President & CEO | 02/14/2023 | 747,207 |
Davis John E | Senior VP, Global Sales | 02/13/2023 | 89,549 |
Horton Amy | VP, Chief Accounting Officer | 12/14/2022 | 26,420 |
Horton Amy | VP, Chief Accounting Officer | 12/14/2022 | 43,783 |
Maney Rochelle L. | VP, Quality | 11/04/2022 | 2,393 |
Maney Rochelle L. | VP, Quality | 08/16/2022 | 164,409 |
Maier Dennis B | SVP, Operations | 08/09/2022 | 124,513 |
SEMEDO ANTHONY B. | Director | 06/01/2022 | 149,997 |
Salveson Jon W | Director | 06/01/2022 | 149,997 |
Burbank Jeffrey H | Director | 06/01/2022 | 149,997 |
Bullock James | Director | 06/01/2022 | 149,997 |
Borgstrom Marna P | Director | 06/01/2022 | 149,997 |
BEVEVINO DANIEL J | Director | 06/01/2022 | 149,997 |
ACKERMAN THOMAS F | Director | 06/01/2022 | 149,997 |
Maney Rochelle L. | VP, Quality | 03/08/2022 | 1,646 |
Barthold Franz Peter | VP, Research & Development | 03/08/2022 | 1,544 |
Maier Dennis B | Vice President, Operations | 03/05/2022 | 23,642 |
Mackin James P | President & CEO | 03/05/2022 | 282,599 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/05/2022 | 46,547 |
Horton Amy | VP, Chief Accounting Officer | 03/05/2022 | 24,553 |
Holloway Jean F | SVP, General Counsel | 03/05/2022 | 39,020 |
Davis John E | Senior VP, Global Sales | 03/05/2022 | 39,020 |
Barthold Franz Peter | VP, Research & Development | 03/05/2022 | 13,057 |
Maney Rochelle L. | VP, Quality | 02/27/2022 | 7,701 |
Maier Dennis B | Vice President, Operations | 02/19/2022 | 5,006 |
Mackin James P | President & CEO | 02/19/2022 | 56,871 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2022 | 9,337 |
Horton Amy | VP, Chief Accounting Officer | 02/19/2022 | 4,544 |
Holloway Jean F | SVP, General Counsel | 02/19/2022 | 7,473 |
Getz Matthew A | VP, Human Resources | 02/19/2022 | 4,331 |
Davis John E | Senior VP, Global Sales | 02/19/2022 | 7,136 |
Barthold Franz Peter | VP, Research & Development | 02/19/2022 | 6,266 |
Stanton Marshall S. | SVP, Clinical & MD Affair | 02/17/2022 | 13,510 |
Maney Rochelle L. | VP, Quality | 02/17/2022 | 17,133 |
Maier Dennis B | Vice President, Operations | 02/17/2022 | 25,603 |
Mackin James P | President & CEO | 02/17/2022 | 282,328 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/17/2022 | 43,995 |
Horton Amy | VP, Chief Accounting Officer | 02/17/2022 | 24,815 |
Holloway Jean F | SVP, General Counsel | 02/17/2022 | 62,633 |
Getz Matthew A | VP, Human Resources | 02/17/2022 | 24,990 |
Davis John E | Senior VP, Global Sales | 02/17/2022 | 35,613 |
GREEN ANDREW M | VP Regulatory | 02/17/2022 | 10,080 |
Barthold Franz Peter | VP, Research & Development | 02/17/2022 | 30,748 |
Mackin James P | President & CEO | 02/09/2022 | 117,018 |
Mackin James P | President & CEO | 02/10/2022 | 117,029 |
Mackin James P | President & CEO | 02/10/2022 | 189,998 |
Mackin James P | President & CEO | 02/09/2022 | 192,989 |
Mackin James P | President & CEO | 02/08/2022 | 117,018 |
Mackin James P | President & CEO | 02/08/2022 | 188,771 |
Mackin James P | President & CEO | 02/07/2022 | 117,018 |
Mackin James P | President & CEO | 02/07/2022 | 184,052 |
Horton Amy | VP, Chief Accounting Officer | 12/09/2021 | 28,230 |
Horton Amy | VP, Chief Accounting Officer | 12/08/2021 | 46,422 |
Davis John E | Senior VP, Global Sales | 11/29/2021 | 10,398 |
SEMEDO ANTHONY B. | Director | 11/29/2021 | 86,661 |
SEMEDO ANTHONY B. | Director | 11/29/2021 | 260,400 |
Maney Rochelle L. | VP, Quality | 11/04/2021 | 4,539 |
Holloway Jean F | SVP, General Counsel | 08/31/2021 | 17,566 |
McCall Ronald D | Director | 08/25/2021 | 145,266 |
Maier Dennis B | Vice President, Operations | 08/23/2021 | 69,613 |
McCall Ronald D | Director | 06/01/2021 | 129,992 |
Davis John E | Senior VP, Global Sales | 05/25/2021 | 141,748 |
Davis John E | Senior VP, Global Sales | 05/25/2021 | 377,880 |
Horton Amy | VP, Chief Accounting Officer | 05/06/2021 | 63,041 |
Horton Amy | VP, Chief Accounting Officer | 05/06/2021 | 171,930 |
Holloway Jean F | SVP, General Counsel | 05/06/2021 | 67,768 |
Holloway Jean F | SVP, General Counsel | 05/06/2021 | 201,849 |
Maier Dennis B | Vice President, Operations | 03/12/2021 | 34,694 |
Mackin James P | President & CEO | 03/12/2021 | 394,938 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/12/2021 | 77,004 |
Horton Amy | VP, Chief Accounting Officer | 03/12/2021 | 43,562 |
Holloway Jean F | SVP, General Counsel | 03/12/2021 | 67,184 |
Davis John E | Senior VP, Global Sales | 03/12/2021 | 56,012 |
Capps Scott B | VP, Clinical Research | 03/12/2021 | 34,895 |
Holloway Jean F | SVP, General Counsel | 03/10/2021 | 42,797 |
Barthold Franz Peter | VP, Research & Development | 03/08/2021 | 1,847 |
Simpson Michael S | SVP, Regulatory Affairs and QA | 03/05/2021 | 7,430 |
Maier Dennis B | Vice President, Operations | 03/05/2021 | 5,010 |
Mackin James P | President & CEO | 03/05/2021 | 36,342 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/05/2021 | 8,774 |
Horton Amy | VP, Chief Accounting Officer | 03/05/2021 | 5,523 |
Holloway Jean F | SVP, General Counsel | 03/05/2021 | 7,308 |
Davis John E | Senior VP, Global Sales | 03/05/2021 | 7,699 |
Capps Scott B | VP, Clinical Research | 03/05/2021 | 5,010 |
Barthold Franz Peter | VP, Research & Development | 03/05/2021 | 2,517 |
Horton Amy | VP, Chief Accounting Officer | 03/01/2021 | 347,711 |
Simpson Michael S | SVP, Regulatory Affairs and QA | 02/23/2021 | 22,869 |
Maier Dennis B | Vice President, Operations | 02/23/2021 | 14,306 |
Mackin James P | President & CEO | 02/23/2021 | 111,372 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/23/2021 | 31,432 |
Horton Amy | VP, Chief Accounting Officer | 02/23/2021 | 15,729 |
Holloway Jean F | VP, General Counsel | 02/23/2021 | 25,156 |
Getz Matthew A | VP, Human Resources | 02/23/2021 | 14,306 |
Davis John E | Senior VP, Global Sales | 02/23/2021 | 24,012 |
Capps Scott B | VP, Clinical Research | 02/23/2021 | 14,306 |
Barthold Franz Peter | VP, Research & Development | 02/23/2021 | 17,889 |
Maier Dennis B | Vice President, Operations | 02/17/2021 | 142,876 |
Maier Dennis B | Vice President, Operations | 02/17/2021 | 177,956 |
Capps Scott B | VP, Clinical Research | 12/15/2020 | 99,700 |
Capps Scott B | VP, Clinical Research | 12/15/2020 | 178,553 |
Horton Amy | VP, Chief Accounting Officer | 12/14/2020 | 29,219 |
Horton Amy | VP, Chief Accounting Officer | 12/14/2020 | 66,460 |
McCall Ronald D | Director | 12/14/2020 | 101,069 |
Maier Dennis B | Vice President, Operations | 12/14/2020 | 40,270 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 12/10/2020 | 166,160 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 12/10/2020 | 383,318 |
Barthold Franz Peter | VP, Research & Development | 12/01/2020 | 13,688 |
Horton Amy | VP, Chief Accounting Officer | 12/01/2020 | 66,460 |
Horton Amy | VP, Chief Accounting Officer | 12/01/2020 | 138,503 |
Maier Dennis B | Vice President, Operations | 11/02/2020 | 27,928 |
Mackin James P | President & CEO | 09/16/2020 | 125,524 |
Davis John E | Senior VP, Global Sales | 09/16/2020 | 166,459 |
Bullock James | Director | 09/16/2020 | 166,273 |
Mackin James P | President & CEO | 09/16/2020 | 125,524 |
Salveson Jon W | Director | 06/01/2020 | 130,001 |
MORGAN HARVEY | Director | 06/01/2020 | 130,001 |
McCall Ronald D | Director | 06/01/2020 | 130,001 |
Burbank Jeffrey H | Director | 06/01/2020 | 130,001 |
Bullock James | Director | 06/01/2020 | 130,001 |
Borgstrom Marna P | Director | 06/01/2020 | 130,001 |
BEVEVINO DANIEL J | Director | 06/01/2020 | 130,001 |
ACKERMAN THOMAS F | Director | 06/01/2020 | 130,001 |
Horton Amy | VP, Chief Accounting Officer | 05/28/2020 | 71,415 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 05/22/2020 | 2,858 |
McCall Ronald D | Director | 05/05/2020 | 39,219 |
Maier Dennis B | Vice President, Operations | 03/12/2020 | 4,574 |
Mackin James P | President & CEO | 03/12/2020 | 54,122 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/12/2020 | 10,383 |
Horton Amy | VP, Chief Accounting Officer | 03/12/2020 | 5,910 |
Holloway Jean F | VP, General Counsel | 03/12/2020 | 9,047 |
Davis John E | Senior VP, Global Sales | 03/12/2020 | 7,550 |
Capps Scott B | VP, Clinical Research | 03/12/2020 | 4,716 |
Bogenschuetz Thomas J | VP, EMEA & General Manager | 03/12/2020 | 6,821 |
Simpson Michael S | SVP, Regulatory Affairs and QA | 03/05/2020 | 16,404 |
Maier Dennis B | Vice President, Operations | 03/05/2020 | 10,246 |
Mackin James P | President & CEO | 03/05/2020 | 111,063 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/05/2020 | 18,299 |
Horton Amy | VP, Chief Accounting Officer | 03/05/2020 | 9,598 |
Holloway Jean F | VP, General Counsel | 03/05/2020 | 15,332 |
Davis John E | Senior VP, Global Sales | 03/05/2020 | 15,332 |
Capps Scott B | VP, Clinical Research | 03/05/2020 | 8,726 |
Bogenschuetz Thomas J | VP, EMEA & General Manager | 03/05/2020 | 22,711 |
McCall Ronald D | Director | 02/24/2020 | 123,340 |
Mackin James P | President & CEO | 02/21/2020 | 261,974 |
Horton Amy | VP, Chief Accounting Officer | 02/21/2020 | 53,893 |
Holloway Jean F | VP, General Counsel | 02/21/2020 | 72,836 |
Davis John E | Senior VP, Global Sales | 02/21/2020 | 73,805 |
Capps Scott B | VP, Clinical Research | 02/21/2020 | 47,212 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/21/2020 | 91,359 |
Holloway Jean F | VP, General Counsel | 01/21/2020 | 81,535 |
Holloway Jean F | VP, General Counsel | 01/21/2020 | 253,744 |
Holloway Jean F | VP, General Counsel | 01/16/2020 | 1,880 |
Holloway Jean F | VP, General Counsel | 01/16/2020 | 5,850 |
Holloway Jean F | VP, General Counsel | 12/12/2019 | 30,720 |
Holloway Jean F | VP, General Counsel | 12/12/2019 | 78,000 |
Capps Scott B | VP, Clinical Research | 11/26/2019 | 61,200 |
Capps Scott B | VP, Clinical Research | 11/26/2019 | 179,108 |
McCall Ronald D | Director | 11/19/2019 | 98,565 |
Mackin James P | President & CEO | 11/13/2019 | 117,355 |
MORGAN HARVEY | Director | 11/06/2019 | 53,476 |
Horton Amy | VP, Chief Accounting Officer | 06/05/2019 | 29,170 |
Capps Scott B | VP, Clinical Research | 05/31/2019 | 57,100 |
McCall Ronald D | Director | 05/24/2019 | 44,499 |
McCall Ronald D | Director | 05/22/2019 | 78,346 |
McCall Ronald D | Director | 05/23/2019 | 28,000 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 05/13/2019 | 2,689 |
Mackin James P | President & CEO | 05/03/2019 | 1,565,690 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 05/03/2019 | 101,996 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 05/03/2019 | 791,959 |
Holloway Jean F | VP, General Counsel | 05/06/2019 | 83,425 |
Holloway Jean F | VP, General Counsel | 05/06/2019 | 276,928 |
Holloway Jean F | VP, General Counsel | 05/01/2019 | 102,400 |
Holloway Jean F | VP, General Counsel | 05/01/2019 | 315,000 |
Saurini Sherry M | VP, Quality | 03/14/2019 | 13,896 |
McDermid James M | SVP, CHRO | 03/14/2019 | 22,216 |
Maier Dennis B | Vice President, Operations | 03/14/2019 | 13,479 |
Mackin James P | President & CEO | 03/14/2019 | 156,165 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/14/2019 | 29,762 |
Horton Amy | VP, Chief Accounting Officer | 03/14/2019 | 16,891 |
Holloway Jean F | VP, General Counsel | 03/14/2019 | 25,944 |
Davis John E | Senior VP, Global Sales | 03/14/2019 | 21,635 |
Capps Scott B | VP, Clinical Research | 03/14/2019 | 13,536 |
Bogenschuetz Thomas J | VP, EMEA & General Manager | 03/14/2019 | 21,256 |
Horton Amy | VP, Chief Accounting Officer | 03/06/2019 | 40,796 |
Horton Amy | VP, Chief Accounting Officer | 03/06/2019 | 194,299 |
Saurini Sherry M | VP, Quality | 03/02/2019 | 41,224 |
Saurini Sherry M | VP, Quality | 03/01/2019 | 23,107 |
McDermid James M | SVP, CHRO | 03/01/2019 | 14,880 |
Mackin James P | President & CEO | 03/01/2019 | 240,659 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/01/2019 | 59,846 |
Horton Amy | VP, Chief Accounting Officer | 03/01/2019 | 33,650 |
Holloway Jean F | VP, General Counsel | 03/01/2019 | 44,728 |
Davis John E | Senior VP, Global Sales | 03/01/2019 | 44,105 |
Capps Scott B | VP, Clinical Research | 03/01/2019 | 32,284 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/22/2019 | 32,406 |
McCall Ronald D | Director | 02/21/2019 | 181,390 |
Holloway Jean F | VP, General Counsel | 02/22/2019 | 25,913 |
Saurini Sherry M | VP, Quality | 02/19/2019 | 50,758 |
Horton Amy | VP, Chief Accounting Officer | 02/19/2019 | 68,293 |
Capps Scott B | VP, Clinical Research | 02/19/2019 | 68,005 |
Davis John E | Senior VP, Global Sales | 02/19/2019 | 84,818 |
Holloway Jean F | VP, General Counsel | 02/19/2019 | 84,588 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2019 | 116,889 |
Mackin James P | President & CEO | 02/19/2019 | 190,402 |
Davis John E | Senior VP, Global Sales | 09/18/2018 | 32,130 |
Davis John E | Senior VP, Global Sales | 09/18/2018 | 112,843 |
Davis John E | Senior VP, Global Sales | 09/10/2018 | 119,408 |
Holloway Jean F | VP, General Counsel | 09/10/2018 | 74,834 |
RONALD C ELKINS | Director | 09/05/2018 | 172,672 |
Capps Scott B | VP, Clinical Research | 08/30/2018 | 47,242 |
Capps Scott B | VP, Clinical Research | 08/30/2018 | 215,921 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/15/2018 | 94,496 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/15/2018 | 531,994 |
MORGAN HARVEY | Director | 08/14/2018 | 77,373 |
MORGAN HARVEY | Director | 08/14/2018 | 79,776 |
MORGAN HARVEY | Director | 08/13/2018 | 168,283 |
Mackin James P | President & CEO | 08/13/2018 | 1,055,457 |
Mackin James P | President & CEO | 08/15/2018 | 100,874 |
Mackin James P | President & CEO | 08/14/2018 | 379,668 |
Mackin James P | President & CEO | 08/13/2018 | 3,315,950 |
Mackin James P | President & CEO | 08/15/2018 | 313,209 |
Mackin James P | President & CEO | 08/14/2018 | 1,194,473 |
Mackin James P | President & CEO | 08/10/2018 | 1,421,968 |
McCall Ronald D | Director | 08/09/2018 | 89,900 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/10/2018 | 337,924 |
Horton Amy | VP, Chief Accounting Officer | 08/10/2018 | 98,550 |
Holloway Jean F | VP, General Counsel | 08/10/2018 | 15,420 |
Holloway Jean F | VP, General Counsel | 08/10/2018 | 50,250 |
RONALD C ELKINS | Director | 08/10/2018 | 38,393 |
Holloway Jean F | VP, General Counsel | 08/07/2018 | 41,120 |
Holloway Jean F | VP, General Counsel | 08/07/2018 | 130,000 |
Davis John E | Senior VP, Global Sales | 07/26/2018 | 55,273 |
Davis John E | Senior VP, Global Sales | 07/26/2018 | 105,121 |
Holloway Jean F | VP, General Counsel | 07/23/2018 | 15,420 |
Holloway Jean F | VP, General Counsel | 07/23/2018 | 45,750 |
Saurini Sherry M | VP, Quality | 01/01/2018 | 3,101 |
McDermid James M | SVP, CHRO | 01/01/2018 | 19,141 |
Holloway Jean F | VP, General Counsel | 01/01/2018 | 13,978 |
Davis John E | Senior VP, Global Sales | 07/06/2018 | 55,273 |
Davis John E | Senior VP, Global Sales | 01/01/2018 | 21,235 |
Davis John E | Senior VP, Global Sales | 07/06/2018 | 101,730 |
Davis John E | Senior VP, Global Sales | 06/14/2018 | 126,788 |
Davis John E | Senior VP, Global Sales | 06/14/2018 | 44,769 |
RONALD C ELKINS | Director | 06/14/2018 | 144,446 |
Horton Amy | VP, Chief Accounting Officer | 06/01/2018 | 28,350 |
Horton Amy | VP, Chief Accounting Officer | 06/01/2018 | 63,168 |
Davis John E | Senior VP, Global Sales | 06/01/2018 | 44,780 |
Davis John E | Senior VP, Global Sales | 06/01/2018 | 122,444 |
RONALD C ELKINS | Director | 05/30/2018 | 81,525 |
Davis John E | Senior VP, Global Sales | 05/16/2018 | 44,780 |
Davis John E | Senior VP, Global Sales | 05/16/2018 | 118,071 |
RONALD C ELKINS | Director | 05/14/2018 | 247,500 |
McCall Ronald D | Director | 05/08/2018 | 6,747 |
McCall Ronald D | Director | 05/10/2018 | 50,782 |
McCall Ronald D | Director | 05/09/2018 | 57,494 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 05/10/2018 | 2,530 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 05/09/2018 | 256,999 |
Horton Amy | VP, Chief Accounting Officer | 05/09/2018 | 31,813 |
Horton Amy | VP, Chief Accounting Officer | 05/09/2018 | 103,764 |
Davis John E | Senior VP, Global Sales | 05/08/2018 | 44,780 |
Davis John E | Senior VP, Global Sales | 05/08/2018 | 113,698 |
RONALD C ELKINS | Director | 05/10/2018 | 126,500 |
RONALD C ELKINS | Director | 05/08/2018 | 47,379 |
RONALD C ELKINS | Director | 05/03/2018 | 48,000 |
Davis John E | Senior VP, Global Sales | 05/03/2018 | 32,140 |
Davis John E | Senior VP, Global Sales | 05/03/2018 | 80,016 |
Davis John E | Senior VP, Global Sales | 04/17/2018 | 32,130 |
Davis John E | Senior VP, Global Sales | 04/17/2018 | 76,659 |
Holloway Jean F | VP, General Counsel | 04/01/2018 | 42,606 |
Matthews William Robert | Senior VP, Operations, Quality | 03/05/2018 | 16,967 |
McCall Ronald D | Director | 03/08/2018 | 105,448 |
RONALD C ELKINS | Director | 03/08/2018 | 44,000 |
Mackin James P | President & CEO | 03/05/2018 | 121,583 |
McDermid James M | SVP, CHRO | 03/05/2018 | 19,093 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/05/2018 | 23,842 |
Horton Amy | VP, Chief Accounting Officer | 03/05/2018 | 13,367 |
Holloway Jean F | VP, General Counsel | 03/05/2018 | 19,571 |
Davis John E | Senior VP, Global Sales | 03/05/2018 | 18,327 |
Capps Scott B | VP, Clinical Research | 03/05/2018 | 11,624 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2018 | 68,328 |
Horton Amy | VP, Chief Accounting Officer | 02/19/2018 | 27,010 |
Capps Scott B | VP, Clinical Research | 02/19/2018 | 40,990 |
Mackin James P | President & CEO | 02/19/2018 | 173,868 |
Matthews William Robert | Senior VP, Operations, Quality | 02/19/2018 | 21,590 |
Mackin James P | President & CEO | 02/19/2018 | 139,430 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2018 | 50,881 |
Horton Amy | VP, Chief Accounting Officer | 02/19/2018 | 27,412 |
Holloway Jean F | VP, General Counsel | 02/19/2018 | 34,255 |
Davis John E | Senior VP, Global Sales | 02/19/2018 | 21,590 |
Capps Scott B | VP, Clinical Research | 02/19/2018 | 27,758 |
Capps Scott B | VP, Clinical Research | 02/13/2018 | 160,415 |
Capps Scott B | VP, Clinical Research | 02/13/2018 | 160,425 |
RONALD C ELKINS | Director | 12/15/2017 | 20,000 |
Gale David C | VP, Research & Development | 11/16/2017 | 118,800 |
Gale David C | VP, Research & Development | 11/16/2017 | 392,500 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/08/2017 | 169,933 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/09/2017 | 154,332 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/08/2017 | 630,550 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/09/2017 | 559,888 |
Horton Amy | VP, Chief Accounting Officer | 11/08/2017 | 76,000 |
RONALD C ELKINS | Director | 11/06/2017 | 19,030 |
Benson James | Director | 10/02/2017 | 45,600 |
Mackin James P | President & CEO | 09/06/2017 | 1,800,679 |
Mackin James P | President & CEO | 09/05/2017 | 951,061 |
RONALD C ELKINS | Director | 09/05/2017 | 22,000 |
Benson James | Director | 07/03/2017 | 39,900 |
Horton Amy | VP, Chief Accounting Officer | 06/27/2017 | 95,575 |
Horton Amy | VP, Chief Accounting Officer | 06/27/2017 | 191,540 |
McCall Ronald D | Director | 05/22/2017 | 127,938 |
Benson James | Director | 04/03/2017 | 33,200 |
Horton Amy | VP, Chief Accounting Officer | 02/26/2017 | 4,796 |
Horton Amy | VP, Chief Accounting Officer | 02/26/2017 | 38,364 |
Gale David C | VP, Research & Development | 02/26/2017 | 64,722 |
Capps Scott B | VP, Clinical Research | 02/26/2017 | 64,722 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/26/2017 | 107,882 |
Capps Scott B | VP, Clinical Research | 02/22/2017 | 116,836 |
Capps Scott B | VP, Clinical Research | 02/22/2017 | 181,776 |
Matthews William Robert | Senior VP, Operations, Quality | 02/19/2017 | 228,770 |
Matthews William Robert | Senior VP, Operations, Quality | 02/19/2017 | 38,157 |
Mackin James P | President & CEO | 02/19/2017 | 1,043,556 |
Mackin James P | President & CEO | 02/19/2017 | 287,920 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2017 | 321,092 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2017 | 76,487 |
Horton Amy | VP, Chief Accounting Officer | 02/19/2017 | 180,625 |
Horton Amy | VP, Chief Accounting Officer | 02/19/2017 | 39,037 |
Holloway Jean F | VP, General Counsel | 02/19/2017 | 228,770 |
Holloway Jean F | VP, General Counsel | 02/19/2017 | 51,681 |
Gale David C | VP, Research & Development | 02/19/2017 | 180,625 |
Gale David C | VP, Research & Development | 02/19/2017 | 43,505 |
Davis John E | Senior VP, Global Sales | 02/19/2017 | 228,770 |
Davis John E | Senior VP, Global Sales | 02/19/2017 | 38,157 |
Capps Scott B | VP, Clinical Research | 02/19/2017 | 180,625 |
Capps Scott B | VP, Clinical Research | 02/19/2017 | 43,677 |
Benson James | Director | 01/03/2017 | 38,200 |
RONALD C ELKINS | Director | 11/23/2016 | 40,000 |
RONALD C ELKINS | Director | 11/14/2016 | 37,302 |
Benson James | Director | 10/31/2016 | 33,501 |
RONALD C ELKINS | Director | 09/20/2016 | 18,000 |
McCall Ronald D | Director | 09/15/2016 | 52,631 |
Matthews William Robert | Senior VP, Operations, Quality | 09/13/2016 | 20,100 |
Holloway Jean F | VP, General Counsel | 09/12/2016 | 51,081 |
Holloway Jean F | VP, General Counsel | 09/12/2016 | 28,920 |
Gale David C | VP, Research & Development | 09/12/2016 | 52,459 |
Gale David C | VP, Research & Development | 09/12/2016 | 21,030 |
RONALD C ELKINS | Director | 09/12/2016 | 17,249 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 09/09/2016 | 498,035 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 09/12/2016 | 51,629 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 09/09/2016 | 202,217 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 09/12/2016 | 31,447 |
Horton Amy | VP, Chief Accounting Officer | 09/09/2016 | 35,057 |
Horton Amy | VP, Chief Accounting Officer | 09/13/2016 | 52,410 |
Benson James | Director | 09/09/2016 | 171,800 |
Horton Amy | VP, Chief Accounting Officer | 07/26/2016 | 94,836 |
Horton Amy | VP, Chief Accounting Officer | 07/26/2016 | 70,100 |
RONALD C ELKINS | Director | 07/26/2016 | 28,000 |
McCall Ronald D | Director | 06/01/2016 | 115,600 |
Benson James | Director | 05/10/2016 | 61,100 |
RONALD C ELKINS | Director | 04/15/2016 | 12,000 |
RONALD C ELKINS | Director | 03/07/2016 | 22,360 |
Mackin James P | President & CEO | 03/03/2016 | 58,806 |
Mackin James P | President & CEO | 03/04/2016 | 50,324 |
Gale David C | VP, Research & Development | 02/26/2016 | 4,385 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/26/2016 | 7,315 |
Horton Amy | VP, Chief Accounting Officer | 02/26/2016 | 2,920 |
Capps Scott B | VP, Clinical Research | 02/26/2016 | 4,385 |
Gale David C | VP, Research & Development | 11/08/2013 | 990 |
Gale David C | VP, Research & Development | 11/11/2013 | 1,496 |
Saurini Sherry M | VP, Quality | 02/19/2016 | 54,211 |
Matthews William Robert | Senior VP, Operations, Quality | 02/19/2016 | 95,375 |
Mackin James P | President & CEO | 02/19/2016 | 435,036 |
Mackin James P | President & CEO | 02/19/2016 | 68,065 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2016 | 133,857 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/22/2016 | 38,378 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2016 | 27,218 |
Horton Amy | VP, Chief Accounting Officer | 02/19/2016 | 75,295 |
Horton Amy | VP, Chief Accounting Officer | 02/19/2016 | 10,885 |
Holloway Jean F | VP, General Counsel | 02/22/2016 | 30,706 |
Holloway Jean F | VP, General Counsel | 02/19/2016 | 95,375 |
Holloway Jean F | VP, General Counsel | 02/19/2016 | 15,575 |
Gale David C | VP, Research & Development | 02/19/2016 | 75,295 |
Gale David C | VP, Research & Development | 02/19/2016 | 16,323 |
Davis John E | Senior VP, Global Sales | 02/19/2016 | 95,375 |
Capps Scott B | VP, Clinical Research | 02/19/2016 | 75,295 |
Capps Scott B | VP, Clinical Research | 02/19/2016 | 16,323 |
Capps Scott B | VP, Clinical Research | 02/19/2016 | 72,450 |
Capps Scott B | VP, Clinical Research | 02/19/2016 | 154,500 |
Horton Amy | VP, Chief Accounting Officer | 02/17/2016 | 43,462 |
Horton Amy | VP, Chief Accounting Officer | 02/17/2016 | 43,470 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/17/2016 | 61,322 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/18/2016 | 38,640 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/17/2016 | 61,341 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/18/2016 | 81,040 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/12/2016 | 14,632 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/15/2016 | 50,355 |
Horton Amy | VP, Chief Accounting Officer | 02/15/2016 | 20,140 |
Horton Amy | VP, Chief Accounting Officer | 02/12/2016 | 5,844 |
Capps Scott B | VP, Clinical Research | 02/15/2016 | 29,807 |
Capps Scott B | VP, Clinical Research | 02/12/2016 | 8,535 |
Gale David C | VP, Research & Development | 02/15/2016 | 29,744 |
Gale David C | VP, Research & Development | 02/12/2016 | 8,535 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 12/28/2015 | 4,830 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 12/28/2015 | 7,700 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/27/2015 | 51,106 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/30/2015 | 25,208 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/27/2015 | 116,708 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/30/2015 | 13,439 |
Benson James | Director | 09/15/2015 | 56,346 |
Benson James | Director | 09/11/2015 | 40,154 |
Benson James | Director | 09/11/2015 | 32,414 |
ANDERSON STEVEN G | Former Executive Chairman | 04/09/2015 | 452,033 |
ANDERSON STEVEN G | Former Executive Chairman | 04/09/2015 | 587,193 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/07/2015 | 18,277 |
Horton Amy | Chief Accounting Officer | 03/07/2015 | 5,329 |
Gale David C | VP, Research & Development | 03/07/2015 | 10,962 |
FRONK DAVID | VP, Regulatory Affairs | 03/07/2015 | 12,791 |
Capps Scott B | VP, Clinical Research | 03/07/2015 | 9,133 |
ANDERSON STEVEN G | Executive Chairman | 03/07/2015 | 57,479 |
Anderson Bruce G. | VP, US Sales &Global Marketing | 03/07/2015 | 7,304 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/26/2015 | 14,890 |
Capps Scott B | VP, Clinical Research | 02/26/2015 | 8,930 |
ANDERSON STEVEN G | Executive Chairman | 02/26/2015 | 46,075 |
FRONK DAVID | VP, Regulatory Affairs | 02/26/2015 | 10,420 |
Horton Amy | Chief Accounting Officer | 02/26/2015 | 5,789 |
Gale David C | VP, Research & Development | 02/26/2015 | 8,930 |
Anderson Bruce G. | VP, US Sales &Global Marketing | 02/26/2015 | 8,930 |
ANDERSON STEVEN G | Executive Chairman | 02/23/2015 | 620,274 |
ANDERSON STEVEN G | Executive Chairman | 02/23/2015 | 620,287 |
FRONK DAVID | VP, Regulatory Affairs | 02/16/2015 | 145,940 |
FRONK DAVID | VP, Regulatory Affairs | 02/16/2015 | 145,950 |
Mackin James P | President & CEO | 02/19/2015 | 339,152 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2015 | 135,663 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/18/2015 | 60,138 |
Lang David P. | VP, Int'l Sales & Marketing | 02/19/2015 | 81,389 |
Horton Amy | Chief Accounting Officer | 02/19/2015 | 54,263 |
Horton Amy | Chief Accounting Officer | 02/18/2015 | 20,039 |
Gale David C | VP, Research & Development | 02/19/2015 | 81,389 |
Gale David C | VP, Research & Development | 02/18/2015 | 36,972 |
FRONK DAVID | VP, Regulatory Affairs | 02/19/2015 | 94,963 |
FRONK DAVID | VP, Regulatory Affairs | 02/18/2015 | 43,518 |
Capps Scott B | VP, Clinical Research | 02/19/2015 | 81,389 |
Capps Scott B | VP, Clinical Research | 02/18/2015 | 30,220 |
ANDERSON STEVEN G | Executive Chairman | 02/18/2015 | 123,294 |
ANDERSON STEVEN G | Executive Chairman | 02/19/2015 | 327,945 |
Anderson Bruce G. | VP, US Sales &Global Marketing | 02/19/2015 | 81,389 |
Anderson Bruce G. | VP, US Sales &Global Marketing | 02/18/2015 | 23,880 |
Horton Amy | Chief Accounting Officer | 02/12/2015 | 8,527 |
ANDERSON STEVEN G | Chairman | 02/12/2015 | 48,587 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/12/2015 | 21,329 |
Anderson Bruce G. | VP, US Sales &Global Marketing | 02/12/2015 | 12,791 |
FRONK DAVID | VP, Regulatory Affairs | 02/12/2015 | 14,934 |
Gale David C | VP, Research & Development | 02/12/2015 | 12,791 |
Capps Scott B | VP, Clinical Research | 02/12/2015 | 12,791 |
Anderson Bruce G. | VP, US Sales &Global Marketing | 12/09/2014 | 35,499 |
Anderson Bruce G. | VP, US Sales &Global Marketing | 12/09/2014 | 40,142 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 12/04/2014 | 278,899 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 12/04/2014 | 267,575 |
Horton Amy | Chief Accounting Officer | 12/02/2014 | 87,562 |
Horton Amy | Chief Accounting Officer | 12/02/2014 | 87,570 |
Anderson Bruce G. | VP, US Sales &Global Marketing | 11/25/2014 | 132,757 |
Anderson Bruce G. | VP, US Sales &Global Marketing | 11/25/2014 | 204,368 |
Gale David C | VP, Research & Development | 11/08/2014 | 1,509 |
RONALD C ELKINS | Director | 11/05/2014 | 40,320 |
Benson James | Director | 11/03/2014 | 102,200 |
Anderson Bruce G. | VP, US Sales &Global Marketing | 10/30/2014 | 52,905 |
Anderson Bruce G. | VP, US Sales &Global Marketing | 10/30/2014 | 104,247 |
Anderson Bruce G. | VP, US Sales and Marketing | 09/08/2014 | 51,200 |
Anderson Bruce G. | VP, US Sales and Marketing | 09/08/2014 | 100,529 |
ANDERSON STEVEN G | Chairman | 09/02/2014 | 201,502 |
Anderson Bruce G. | VP, US Sales and Marketing | 08/25/2014 | 25,600 |
Anderson Bruce G. | VP, US Sales and Marketing | 08/25/2014 | 50,255 |
Anderson Bruce G. | VP, US Sales and Marketing | 08/18/2014 | 48,300 |
Anderson Bruce G. | VP, US Sales and Marketing | 08/18/2014 | 105,182 |
Burris Jeffrey W | Vice President & Gen. Counsel | 08/15/2014 | 34,993 |
Burris Jeffrey W | Vice President & Gen. Counsel | 08/15/2014 | 35,000 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/14/2014 | 1,158 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/13/2014 | 96,142 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/14/2014 | 1,250 |
LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/13/2014 | 103,849 |
Burris Jeffrey W | Vice President & Gen. Counsel | 08/13/2014 | 56,320 |
Burris Jeffrey W | Vice President & Gen. Counsel | 08/13/2014 | 115,500 |
RONALD C ELKINS | Director | 07/29/2014 | 24,175 |
ANDERSON STEVEN G | President, CEO and Chairman | 07/28/2014 | 185,501 |
Anderson Bruce G. | VP, US Sales and Marketing | 07/28/2014 | 24,150 |
Anderson Bruce G. | VP, US Sales and Marketing | 07/28/2014 | 47,424 |
Horton Amy | Chief Accounting Officer | 06/09/2014 | 23,152 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 05/16/2014 | 77,088 |
ANDERSON STEVEN G | President, CEO and Chairman | 05/12/2014 | 263,051 |
ANDERSON STEVEN G | President, CEO and Chairman | 05/13/2014 | 11,704 |
Anderson Bruce G. | VP, US Sales and Marketing | 05/06/2014 | 123,754 |
Anderson Bruce G. | VP, US Sales and Marketing | 05/02/2014 | 25,244 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 03/07/2014 | 17,164 |
Horton Amy | Chief Accounting Officer | 03/07/2014 | 5,142 |
Gale David C | VP-Research and Development | 03/07/2014 | 10,117 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 03/07/2014 | 12,012 |
Burris Jeffrey W | Vice President & Gen. Counsel | 03/07/2014 | 12,012 |
Capps Scott B | VP-Clinical Research | 03/07/2014 | 8,577 |
ANDERSON STEVEN G | President, CEO and Chairman | 03/07/2014 | 61,707 |
Anderson Bruce G. | VP, US Sales and Marketing | 03/07/2014 | 6,860 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 02/24/2014 | 103,382 |
Horton Amy | Chief Accounting Officer | 02/24/2014 | 29,820 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/24/2014 | 71,682 |
Capps Scott B | VP-Clinical Research | 02/24/2014 | 50,908 |
Burris Jeffrey W | Vice President & Gen. Counsel | 02/24/2014 | 71,761 |
ANDERSON STEVEN G | President, CEO and Chairman | 02/24/2014 | 257,888 |
Anderson Bruce G. | VP, US Sales and Marketing | 02/24/2014 | 41,089 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 02/21/2014 | 31,612 |
Horton Amy | Chief Accounting Officer | 02/21/2014 | 12,306 |
Gale David C | VP-Research and Development | 02/21/2014 | 19,306 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/21/2014 | 21,528 |
Capps Scott B | VP-Clinical Research | 02/21/2014 | 18,484 |
Burris Jeffrey W | Vice President & Gen. Counsel | 02/21/2014 | 21,528 |
Anderson Bruce G. | VP, US Sales and Marketing | 02/21/2014 | 18,630 |
ANDERSON STEVEN G | President, CEO and Chairman | 02/21/2014 | 79,054 |
Horton Amy | Chief Accounting Officer | 02/18/2014 | 19,567 |
Horton Amy | Chief Accounting Officer | 02/18/2014 | 19,575 |
ANDERSON STEVEN G | President, CEO and Chairman | 12/30/2013 | 554,614 |
ANDERSON STEVEN G | President, CEO and Chairman | 12/30/2013 | 554,625 |
Capps Scott B | VP-Clinical Research | 11/27/2013 | 226,500 |
Capps Scott B | VP-Clinical Research | 11/27/2013 | 265,103 |
Burris Jeffrey W | Vice President & Gen. Counsel | 11/26/2013 | 35,000 |
Burris Jeffrey W | Vice President & Gen. Counsel | 11/26/2013 | 52,500 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 11/11/2013 | 88,148 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 11/12/2013 | 93,630 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 11/08/2013 | 42,342 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 11/08/2013 | 42,352 |
Burris Jeffrey W | Vice President & Gen. Counsel | 11/11/2013 | 35,000 |
Burris Jeffrey W | Vice President & Gen. Counsel | 11/11/2013 | 50,000 |
Gale David C | VP-Research and Development | 11/08/2013 | 990 |
Gale David C | VP-Research and Development | 11/11/2013 | 1,496 |
ANDERSON STEVEN G | President, CEO and Chairman | 11/07/2013 | 221,448 |
ANDERSON STEVEN G | President, CEO and Chairman | 11/06/2013 | 289,516 |
ANDERSON STEVEN G | President, CEO and Chairman | 11/05/2013 | 427,228 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 11/04/2013 | 108,750 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 11/04/2013 | 114,961 |
Burris Jeffrey W | Vice President & Gen. Counsel | 11/04/2013 | 35,000 |
Burris Jeffrey W | Vice President & Gen. Counsel | 11/04/2013 | 47,650 |
Horton Amy | Chief Accounting Officer | 11/01/2013 | 58,718 |
Horton Amy | Chief Accounting Officer | 11/01/2013 | 58,725 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 10/29/2013 | 217,494 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 10/29/2013 | 217,500 |
RONALD C ELKINS | Director | 10/29/2013 | 18,000 |
Burris Jeffrey W | Vice President & Gen. Counsel | 10/29/2013 | 35,000 |
Burris Jeffrey W | Vice President & Gen. Counsel | 10/29/2013 | 45,000 |
Anderson Bruce G. | VP, US Sales and Marketing | 08/27/2013 | 28,464 |
RONALD C ELKINS | Director | 08/05/2013 | 14,041 |
Horton Amy | Chief Accounting Officer | 08/08/2013 | 17,675 |
McCall Ronald D | Director | 08/01/2013 | 42,588 |
Burris Jeffrey W | Vice President & Gen. Counsel | 07/12/2013 | 36,218 |
Burris Jeffrey W | Vice President & Gen. Counsel | 07/12/2013 | 36,225 |
McCall Ronald D | Director | 06/06/2013 | 12,221 |
McCall Ronald D | Director | 06/05/2013 | 12,380 |
RONALD C ELKINS | Director | 05/31/2013 | 13,831 |
Lang David P. | Sr. VP, Intl Sales & Marketing | 03/07/2013 | 8,226 |
Gale David C | VP-Research and Development | 03/07/2013 | 12,342 |
Horton Amy | Chief Accounting Officer | 03/07/2013 | 5,028 |
ANDERSON STEVEN G | President, CEO and Chairman | 03/07/2013 | 52,878 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 03/07/2013 | 18,349 |
Anderson Bruce G. | VP, US Sales and Marketing | 03/07/2013 | 8,226 |
Capps Scott B | VP-Clinical Research | 03/07/2013 | 9,302 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 03/07/2013 | 25,585 |
Burris Jeffrey W | Vice President & Gen. Counsel | 03/07/2013 | 17,018 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 02/22/2013 | 36,053 |
Horton Amy | Chief Accounting Officer | 02/22/2013 | 8,091 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/22/2013 | 28,984 |
Capps Scott B | VP-Clinical Research | 02/22/2013 | 14,504 |
Burris Jeffrey W | Vice President & Gen. Counsel | 02/22/2013 | 26,940 |
ANDERSON STEVEN G | President, CEO and Chairman | 02/22/2013 | 85,037 |
Anderson Bruce G. | VP, US Sales and Marketing | 02/22/2013 | 13,238 |
SEERY GERALD B | Sr. VP, Sales and Marketing | 11/30/2012 | 25,906 |
McCall Ronald D | Director | 11/14/2012 | 34,322 |
Gale David C | VP-Research and Development | 11/08/2012 | 1,407 |
RONALD C ELKINS | Director | 08/27/2012 | 16,031 |
Salveson Jon W | Director | 06/07/2012 | 119,837 |
RONALD C ELKINS | Director | 06/01/2012 | 13,704 |
McCall Ronald D | Director | 05/30/2012 | 27,115 |
McCall Ronald D | Director | 05/29/2012 | 18,276 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 05/21/2012 | 4,900 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 05/21/2012 | 5,385 |
RONALD C ELKINS | Director | 02/21/2012 | 28,025 |
Capps Scott B | VP-Clinical Research | 02/16/2012 | 9,700 |
Horton Amy | Chief Accounting Officer | 02/16/2012 | 4,742 |
SEERY GERALD B | Sr. VP, Sales and Marketing | 02/16/2012 | 14,549 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 02/16/2012 | 19,770 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/16/2012 | 11,793 |
Burris Jeffrey W | Vice President & Gen. Counsel | 02/16/2012 | 11,195 |
ANDERSON STEVEN G | President, CEO and Chairman | 02/16/2012 | 41,232 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/07/2012 | 109,424 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/07/2012 | 109,427 |
SEERY GERALD B | Sr. VP, Sales and Marketing | 02/03/2012 | 123,429 |
SEERY GERALD B | Sr. VP, Sales and Marketing | 02/03/2012 | 123,434 |
HEACOX ALBERT E | Sr. VP Research and Devl | 12/31/2011 | 11,678 |
RONALD C ELKINS | Director | 12/06/2011 | 13,681 |
McCall Ronald D | Director | 11/22/2011 | 43,500 |
ANDERSON STEVEN G | President, CEO and Chairman | 11/18/2011 | 22,464 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 11/21/2011 | 17,355 |
SEERY GERALD B | Sr. VP, Sales and Marketing | 08/19/2011 | 61,419 |
SEERY GERALD B | Sr. VP, Sales and Marketing | 08/19/2011 | 89,671 |
HEACOX ALBERT E | Sr. VP Research and Devl | 08/15/2011 | 65,660 |
HEACOX ALBERT E | Sr. VP Research and Devl | 08/15/2011 | 65,663 |
ANDERSON STEVEN G | President, CEO and Chairman | 08/09/2011 | 269,873 |
ANDERSON STEVEN G | President, CEO and Chairman | 08/09/2011 | 269,875 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 07/26/2011 | 58,475 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 07/26/2011 | 58,480 |
SEERY GERALD B | Sr. VP, Sales and Marketing | 07/14/2011 | 429 |
SEERY GERALD B | Sr. VP, Sales and Marketing | 07/13/2011 | 1,275 |
SEERY GERALD B | Sr. VP, Sales and Marketing | 07/13/2011 | 1,800 |
SEERY GERALD B | Sr. VP, Sales and Marketing | 07/14/2011 | 606 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 07/07/2011 | 81,499 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 07/07/2011 | 73,100 |
Horton Amy | Chief Accounting Officer | 07/07/2011 | 38,250 |
Horton Amy | Chief Accounting Officer | 07/07/2011 | 38,250 |
RONALD C ELKINS | Director | 05/05/2011 | 21,613 |
Benson James | Director | 05/04/2011 | 50,000 |
Benson James | Director | 05/04/2011 | 54,289 |
BEVEVINO DANIEL J | Director | 05/05/2011 | 50,000 |
BEVEVINO DANIEL J | Director | 05/05/2011 | 53,696 |
ACKERMAN THOMAS F | Director | 05/03/2011 | 50,000 |
ACKERMAN THOMAS F | Director | 05/03/2011 | 55,296 |
ANDERSON STEVEN G | President, CEO and Chairman | 04/26/2011 | 50,295 |
ANDERSON STEVEN G | President, CEO and Chairman | 04/26/2011 | 50,300 |
McCall Ronald D | Director | 04/13/2011 | 16,000 |
ANDERSON STEVEN G | President, CEO and Chairman | 02/19/2011 | 15,090 |
Horton Amy | Chief Accounting Officer | 02/19/2011 | 2,127 |
FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/19/2011 | 5,429 |
SEERY GERALD B | Sr. VP, Sales and Marketing | 02/19/2011 | 5,923 |
HEACOX ALBERT E | Sr. VP Research and Devl | 02/19/2011 | 6,326 |
LEE DAVID ASHLEY | Exec. VP, COO and CFO | 02/19/2011 | 8,871 |
Burris Jeffrey W | Vice President & Gen. Counsel | 02/04/2011 | 17,231 |
McCall Ronald D | Director | 11/15/2010 | 17,430 |
McCall Ronald D | Director | 11/12/2010 | 41,238 |
RONALD C ELKINS | Director | 11/12/2010 | 12,008 |
Capps Scott B | VP-Clinical Research | 07/30/2010 | 8,694 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 6,844,308 | 0.00312% | 1.81% | Other |
ROYCE & ASSOCIATES LP | 1,084,704 | 0.18% | 9.79% | Value |
GEODE CAPITAL MANAGEMENT, LLC | 836,414 | 0.00156% | 4.76% | Other |
FIRST EAGLE INVESTMENT MANAGEMENT, LLC | 527,537 | 0.02% | 0.19% | Value |
D. E. SHAW & CO., INC. | 101,603 | 0.00159% | 52.52% | Other |
TUDOR INVESTMENT CORP ET AL | 80,313 | 0.01% | 138.98% | Event Driven, Other |
BALYASNY ASSET MANAGEMENT L.P. | 64,932 | 0.00218% | New | Event Driven |
AQR CAPITAL MANAGEMENT LLC | 23,212 | 0.00078% | New | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View